Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005322	s-ige	u/ml (u/ml)	22871	29120	0.02%
3005322	p-ige	u/ml (u/ml)	3235	4003	0.52%
3005322	s-ige	— (—)	2368	2658	100.00%	Distribution not available
3005322	p-ige	— (—)	238	254	100.00%	Distribution not available
3005322	s-immunoglobuliinie	u/ml (u/ml)	92	96	0.00%
3005322	immunoglobuliinie	u/ml (u/ml)	13	16	0.00%
3005322	s-ige	u/l (u/ml)	9	9	0.00%
3005322	s-immunoglobuliinie	— (—)	7	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Immunodeficiencies

581

1067

7.43

323.01

1.9

1.3

215.35

206.97

u/ml

0.06

481

982

Certain disorders involving the immune mechanism

1339

4449

3.38

320.76

1.7

1.3

224.08

219.50

u/ml

0.04

1185

4130

Haemorrhage from respiratory passages

1499

4645

3.07

320.01

1.4

1.2

221.48

318.15

u/ml

3.12

1387

4253

Any reimbursement code in KELA

3562

8710

2.15

311.56

1.4

1.2

276.79

157.38

u/ml

7.61

3328

8032

Ethmoidectomy

1236

2953

5.07

307.65

1.8

1.2

271.02

209.23

u/ml

1.06

1184

2745

4885

9700

5.98

307.65

1.7

1.2

349.17

208.94

u/ml

5.29

4647

8799

Asthma (only as main-diagnosis), excluding more controls

8657

6946

8.56

307.65

1.6

1.1

311.56

211.24

u/ml

4.35

8275

6313

Other and unspecified dermatitis

3893

12259

3.52

307.65

1.3

360.21

145.92

u/ml

13.96

3641

11282

Other chronic obstructive pulmonary disease, including avohilmo

2458

8735

2.46

307.65

1.4

1.3

347.52

245.50

u/ml

2.98

2291

8017

Other acute lower respiratory infections

3109

13305

2.37

307.65

1.6

1.3

312.72

252.02

u/ml

1.51

2877

12264

Asthma-related infections

6057

12352

5.62

307.65

1.6

1.2

341.54

209.40

u/ml

6.57

5759

11197

Asthma (diagnoses ohter than nonallergic)

9307

17661

5.08

307.65

1.6

1.2

339.00

202.75

u/ml

10.90

8883

16096

Asthma, excluding more controls

8678

6946

7.67

307.65

1.5

1.1

313.23

211.24

u/ml

4.54

8261

6313

COPD/asthma/ILD related infections

5734

14890

2.01

307.65

1.4

1.2

254.94

224.34

u/ml

0.69

5283

13755

ILD medications: immunosuppressive drugs

3374

14238

2.32

307.65

1.4

1.2

447.61

174.22

u/ml

8.78

3159

13065

ILD, hospital admissions

974

2472

4.47

307.65

1.5

1.2

248.61

233.40

u/ml

0.19

908

2242

Pain in throat and chest

4575

12196

2.36

307.65

1.4

1.2

186.63

288.83

u/ml

7.32

4245

11255

Atopic dermatitis, strict definition with reimbursement

2722

8277

3.60

307.65

1.6

1.3

992.12

135.17

u/ml

30.87

2591

7629

Asthma

8854

7159

7.61

307.65

1.5

1.1

313.84

217.42

u/ml

4.21

8423

6503

FESS (DNB20)

1216

2851

5.20

307.65

1.8

1.2

274.24

208.73

u/ml

1.12

1165

2648

Urticaria and erythema

3064

10522

3.28

307.65

1.5

1.3

356.52

222.98

u/ml

3.73

2898

9698

Interstitial lung disease

976

2497

4.42

307.65

1.5

1.2

248.65

231.99

u/ml

0.22

910

2263

Other diseases of upper respiratory tract

6584

14661

2.47

307.65

1.4

1.2

268.29

226.61

u/ml

1.28

6140

13467

Biological medicines for asthma

593

442

65.64

307.65

2.7

1.3

872.11

211.33

u/ml

6.79

586

404

Bronchitis

6058

20515

1.94

307.65

1.5

1.2

288.55

236.41

u/ml

1.39

5607

18980

Other soft tissue disorders, not elsewhere classified

5090

16250

1.91

307.65

1.3

192.60

280.50

u/ml

7.36

4730

15015

Abnormal findings on diagnostic imaging of lung

2759

9102

3.15

307.65

1.5

1.3

233.58

255.52

u/ml

0.51

2576

8356

Non-allergic asthma (mode)

2019

2493

9.76

307.65

1.5

1.1

151.55

225.46

u/ml

2.00

1918

2243

Cough

3927

7826

5.52

307.65

1.4

1.2

177.59

284.97

u/ml

5.24

3716

7207

Sleep apnoea, including avohilmo

5426

17467

2.02

307.65

1.3

221.76

253.34

u/ml

1.07

5071

16143

Other chronic obstructive pulmonary disease

1989

4539

3.87

307.65

1.4

1.1

322.33

247.81

u/ml

1.68

1860

4064

Vasomotor and allergic rhinitis

3703

9325

4.50

307.65

1.5

1.2

443.22

212.98

u/ml

12.50

3531

8559

Dermatitis

4542

14677

3.40

307.65

1.3

380.73

146.31

u/ml

17.25

4238

13531

Asthma, hospital admissions 3, pneumonia

3085

6173

5.76

307.65

1.7

1.2

317.26

219.76

u/ml

3.82

2933

5549

Abnormalities of breathing

6932

12976

3.38

307.65

1.4

1.2

202.82

290.81

u/ml

6.09

6497

11965

Diseases of the respiratory system

3546

5710

3.29

307.65

1.3

1.1

209.73

194.23

u/ml

0.38

3286

5182

Urticaria

2715

8653

3.60

307.65

1.5

1.3

289.96

220.88

u/ml

1.61

2581

7969

Other interstitial pulmonary diseases

976

2487

4.44

307.65

1.5

1.2

248.65

231.25

u/ml

0.23

910

2254

Allergic contact dermatitis

1119

3161

4.08

307.65

1.4

1.3

344.32

129.97

u/ml

9.57

1048

2908

Inflammatory bowel disease treatment related agents

8637

17054

3.07

307.65

1.5

1.2

348.93

193.60

u/ml

12.18

8125

15657

Pollen allergy

2201

5700

4.66

307.65

1.5

1.3

475.39

202.69

u/ml

8.96

2112

5245

Gastro-oesophageal reflux disease

3688

15947

2.10

307.65

1.4

1.3

175.27

252.54

u/ml

4.66

3439

14786

ILD medications

8417

16093

3.06

307.65

1.5

1.2

367.59

178.66

u/ml

16.27

7913

14750

Interstitial lung disease endpoints

976

2497

4.42

307.65

1.5

1.2

248.65

231.99

u/ml

0.22

910

2263

COPD

2129

4732

3.95

307.65

1.4

1.1

320.10

243.62

u/ml

1.89

1994

4246

Non-allergic asthma (mode), excluding more controls

2018

2472

9.84

307.65

1.5

1.1

151.62

218.69

u/ml

1.72

1917

2227

Sleep disorders (combined)

5935

17809

1.81

307.65

1.3

241.15

258.96

u/ml

0.35

5493

16438

Eosinophilic disease (BM)

258

119

37.56

307.65

2.7

1.1

620.61

82.61

u/ml

4.00

249

103

Symptoms and signs involving the circulatory and respiratory systems

6703

13028

2.74

307.65

1.4

1.2

211.44

290.32

u/ml

4.53

6214

12010

Asthma and allergy, excluding more controls

1660

2235

9.22

307.65

1.8

1.1

726.65

174.37

u/ml

16.33

1602

2012

6472

16498

2.12

307.65

1.4

1.2

270.54

228.22

u/ml

1.09

5982

15215

Other and unspecified effects of external causes

2061

7964

2.86

307.65

1.5

1.3

375.79

222.50

u/ml

4.73

1976

7348

Early onset COPD, excluding more controls

1174

2090

6.22

307.65

1.5

1.1

341.37

282.09

u/ml

0.61

1096

1890

ILD, hospital admission 2, with pulmonary infections

667

1297

5.92

307.65

1.6

1.2

228.95

214.53

u/ml

0.15

622

1183

Pain in joint

3403

9557

2.40

307.65

1.4

1.3

189.98

312.52

u/ml

8.24

3174

8834

Examination and observation for other reasons

3291

7918

2.53

307.65

1.4

1.2

217.62

257.84

u/ml

0.95

3069

7309

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4915

14887

2.09

307.65

1.5

1.2

266.43

224.29

u/ml

1.63

4537

13752

Medical observation and evaluation for suspected diseases and conditions

3392

7961

2.27

307.65

1.4

1.2

261.07

257.48

u/ml

0.03

3156

7349

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3267

11240

3.05

307.65

1.5

1.2

210.70

232.08

u/ml

0.52

3056

10342

Asthma, hospital admissions , main diagnosis only

9121

17726

5.33

307.65

1.6

1.2

314.27

211.31

u/ml

6.85

8725

16129

Other special examinations and investigations of persons without complaint or reported diagnosis

3674

7962

2.45

307.65

1.3

1.2

244.40

257.45

u/ml

0.24

3414

7350

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

943

938

8.34

307.65

1.6

1.2

247.43

299.20

u/ml

0.52

877

865

Undetermined asthma

1450

1625

11.23

307.65

1.7

1.1

225.69

213.68

u/ml

0.13

1384

1462

Acute bronchitis

2356

9632

2.56

307.65

1.6

1.3

249.83

249.93

u/ml

0.00

2181

8880

Allergic rhinitis

3248

8950

4.22

307.65

1.5

1.2

459.22

186.89

u/ml

13.48

3104

8218

Undetermined asthma, excluding more controls

1450

1606

11.37

307.65

1.7

1.1

225.69

202.38

u/ml

0.28

1384

1441

COPD (mode)

1321

2413

4.60

307.65

1.3

1.1

318.77

271.42

u/ml

0.55

1221

2164

ILD medications: prednisolone, methylprednisolone, prednisone

8446

15615

3.29

307.65

1.5

1.2

357.94

175.99

u/ml

15.79

7950

14317

Other and unspecified urticaria

1690

5314

3.66

307.65

1.5

1.3

239.23

222.24

u/ml

0.25

1605

4902

Bronchiectasis

893

822

14.70

307.65

1.9

1.1

232.00

165.39

u/ml

0.87

846

732

Obesity related asthma

3457

6640

6.27

307.65

1.5

1.2

251.10

209.05

u/ml

1.50

3315

6012

Asthma-related pneumonia or sepsis

3085

6173

5.76

307.65

1.7

1.2

317.26

219.76

u/ml

3.82

2933

5549

Later onset COPD, excluding more controls

786

1214

5.35

307.65

1.3

1.1

289.20

302.88

u/ml

0.10

736

1071

Asthma-related pneumonia

3081

6158

5.77

307.65

1.7

1.2

317.48

219.77

u/ml

3.83

2929

5535

Asthma and allergy

1660

2167

9.52

307.65

1.8

1.1

726.65

173.37

u/ml

16.28

1602

1945

Asthma (mode)

8689

7201

7.58

307.65

1.5

1.1

316.19

218.25

u/ml

4.27

8276

6542

Asthma, unspecified (mode), excluding more controls

5351

6296

7.44

307.65

1.4

1.1

256.47

213.83

u/ml

0.82

5074

5724

Excluding asthma or asthma-COPD overlap

4955

7225

3.68

307.65

1.4

1.1

231.59

217.42

u/ml

0.30

4617

6563

Nasal polyp

1404

3236

4.95

307.65

1.7

1.2

395.72

240.08

u/ml

2.33

1357

2979

Atopic dermatitis

4538

14040

2.90

307.65

1.4

1.3

690.40

135.43

u/ml

33.09

4265

12993

Dyspnoea

6308

17643

2.86

307.65

1.4

1.3

203.87

253.55

u/ml

2.91

5907

16278

Atopic dermatitis, strict definition

2522

9392

2.94

307.65

1.5

1.3

1053.23

140.14

u/ml

30.16

2404

8655

COPD differential diagnosis

4933

7205

3.67

307.65

1.4

1.1

228.26

218.15

u/ml

0.20

4596

6546

Diseases of the skin and subcutaneous tissue

5750

13238

2.28

307.65

1.3

354.30

139.06

u/ml

15.61

5337

12174

Chronic rhinitis, nasopharyngitis and pharyngitis

2839

7113

4.60

307.65

1.5

1.2

208.39

210.64

u/ml

0.04

2658

6544

Acute sinusitis

3424

13977

2.43

307.65

1.6

1.2

243.50

224.11

u/ml

0.47

3187

12921

Other respiratory diseases principally affecting the interstitium

1124

2999

4.20

307.65

1.6

1.2

251.57

246.38

u/ml

0.06

1051

2735

4915

14887

2.09

307.65

1.5

1.2

266.43

224.29

u/ml

1.63

4537

13752

Allergic asthma (mode)

2613

3990

7.67

307.65

1.8

1.1

572.04

207.64

u/ml

14.46

2514

3617

COPD/asthma related infections

5734

14890

2.01

307.65

1.4

1.2

254.94

224.34

u/ml

0.69

5283

13755

Asthma, unspecified (mode)

5409

6480

7.32

307.65

1.4

1.1

255.35

221.01

u/ml

0.61

5129

5887

Dermatitis and eczema

8284

18719

2.97

307.65

1.4

1.3

464.01

146.95

u/ml

33.45

7719

17273

Chronic lower respiratory diseases

11158

15133

4.40

307.65

1.5

1.2

309.56

194.86

u/ml

9.87

10561

13763

Asthma, including avohilmo

11488

15311

4.77

307.65

1.5

1.2

300.23

203.98

u/ml

7.67

10844

13955

Suggestive for eosinophilic asthma

1089

1335

10.96

307.65

2.0

1.2

414.00

218.73

u/ml

2.59

1066

1196

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3673

13785

2.54

307.65

1.5

1.3

214.66

247.05

u/ml

1.13

3416

12712

Adverse effects, not elsewhere classified

1763

5512

3.70

307.65

1.5

1.3

398.85

217.10

u/ml

4.92

1696

5080

Asthma, hospital admission 2, infections

6057

12352

5.62

307.65

1.6

1.2

341.54

209.40

u/ml

6.57

5759

11197

Acute upper respiratory infections of multiple and unspecified sites

4255

16452

2.01

307.65

1.5

1.2

278.77

227.64

u/ml

0.95

3945

15204

Allergic asthma (mode), excluding more controls

2613

3960

7.72

307.65

1.8

1.1

572.04

203.72

u/ml

14.73

2514

3584

Asthma/COPD (KELA code 203)

8935

15088

4.58

307.65

1.5

1.2

339.47

195.12

u/ml

11.07

8472

13725

Other pulmonary diagnosis

5028

7225

3.74

307.65

1.4

1.1

233.13

217.42

u/ml

0.34

4687

6563

Chronic sinusitis

3592

9613

4.23

307.65

1.6

1.2

232.72

212.21

u/ml

0.57

3382

8830

Acute upper respiratory infections

5888

18763

2.02

307.65

1.5

1.2

271.85

236.41

u/ml

0.77

5459

17330

Asthma and opportunity respiratory infection

648

536

18.64

307.65

2.3

1.1

277.47

180.29

u/ml

1.70

625

473

ILD differential diagnosis

4931

7201

3.67

307.65

1.4

1.1

228.32

218.25

u/ml

0.20

4594

6542

Asthma (only as main-diagnosis)

8757

7159

8.47

307.65

1.6

1.1

313.95

217.42

u/ml

4.07

8370

6503

Sleep apnoea

5070

16920

2.03

307.65

1.4

1.3

226.80

245.10

u/ml

0.51

4744

15636

First line medication for Crohn's disease

7898

15903

2.88

307.65

1.5

1.2

353.64

185.24

u/ml

12.22

7418

14593

Oral corticosteroids

8656

16106

3.50

307.65

1.5

1.2

357.57

185.68

u/ml

15.12

8156

14800

Episodal and paroxysmal disorders

5832

17160

1.79

307.56

1.3

241.83

267.63

u/ml

0.51

5399

15854

Diseases of oesophagus, stomach and duodenum

5571

19237

1.80

307.34

1.4

1.3

197.14

254.15

u/ml

3.89

5187

17830

Headache

3774

15732

2.01

306.59

1.4

1.3

218.93

251.99

u/ml

0.52

3490

14560

Low back pain

4057

15500

1.96

303.65

1.3

186.78

273.78

u/ml

6.19

3747

14351

Deviated nasal septum

1617

6073

2.84

301.00

1.5

1.2

291.05

261.38

u/ml

0.38

1509

5589

Other specific joint derangements/joint disorders

4202

14574

1.95

300.63

1.4

1.3

195.82

271.55

u/ml

4.56

3919

13491

Childhood asthma (age<16), excluding more controls

961

2020

4.12

298.39

1.6

1.1

918.20

197.79

u/ml

6.26

905

1829

Childhood asthma (age<16)

962

2026

4.11

298.16

1.6

1.1

917.19

197.99

u/ml

6.25

906

1835

ILD, hospital admissions 1, main diag only

858

2241

4.34

297.50

1.6

1.2

247.93

233.97

u/ml

0.16

802

2030

COPD, hospital admissions

1990

6925

2.57

295.87

1.4

1.3

322.15

267.73

u/ml

1.20

1862

6329

General symptoms and signs

5747

16775

1.78

294.08

1.4

1.3

255.81

254.65

u/ml

0.02

5301

15542

Influenza and pneumonia

5635

21140

1.76

292.10

1.5

1.2

263.40

241.74

u/ml

0.67

5215

19578

COPD, early/later onset

1994

6990

2.54

289.62

1.4

1.3

322.47

268.69

u/ml

1.18

1865

6386

Pneumonias (Asthma/COPD co-morbidities)

5320

20908

1.77

286.95

1.5

1.3

264.79

241.24

u/ml

0.71

4917

19384

Disorders of conjunctiva

4617

21107

1.83

285.06

1.4

1.3

387.40

211.30

u/ml

6.86

4344

19458

All pneumoniae

5342

20971

1.77

284.32

1.5

1.3

264.66

241.55

u/ml

0.70

4937

19439

Pneumonia, organism unspecified

4728

18874

1.83

283.18

1.5

1.2

280.36

244.28

u/ml

1.12

4365

17476

Conjunctivitis

4316

20316

1.86

278.58

1.4

1.3

400.31

209.26

u/ml

7.15

4068

18731

Dorsalgia

5193

16084

1.79

277.36

1.3

202.08

280.19

u/ml

5.26

4797

14877

Immunodeficiency with predominantly antibody defects

392

584

10.40

272.49

1.8

1.2

75.00

194.11

u/ml

2.13

312

540

Pain in limb

4217

15662

1.87

272.08

1.4

1.3

198.80

272.36

u/ml

5.04

3924

14478

Dermatographic urticaria

684

1664

5.10

268.99

1.6

1.3

248.43

188.41

u/ml

1.21

650

1538

Pruritus

803

2165

4.24

267.44

1.4

1.2

326.25

121.67

u/ml

5.07

756

1991

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1950

3892

2.62

267.39

1.3

1.2

196.36

302.80

u/ml

4.56

1807

3565

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5115

20690

1.75

263.80

1.5

1.3

271.43

241.03

u/ml

0.97

4722

19184

Lower back pain or/and sciatica

5398

21270

1.72

258.64

1.3

195.34

256.03

u/ml

4.36

4989

19703

Abnormalities of heart beat

1679

6772

2.56

257.31

1.3

1.2

160.60

288.59

u/ml

4.60

1541

6219

Voice disturbances

1599

6568

2.64

252.26

1.5

1.3

151.33

226.45

u/ml

3.04

1493

6035

Non-allergic asthma

648

1575

4.77

249.23

1.3

106.82

134.93

u/ml

1.47

609

1443

COPD, hospital admissions 1, only main diagnosis

1491

5007

2.70

245.95

1.5

1.3

305.67

254.60

u/ml

1.21

1397

4574

Other dorsopathies, not elsewhere classified

5174

16174

1.73

244.51

1.3

201.99

281.43

u/ml

5.54

4788

14959

Parasetamol

3978

11129

1.87

243.48

1.3

232.26

294.87

u/ml

2.21

3688

10307

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3220

16961

1.94

243.41

1.4

1.3

448.44

195.94

u/ml

7.63

3060

15651

ILD, hospital admissions 3, with pneumonia sepsis

532

1132

5.35

240.02

1.6

1.2

205.04

213.12

u/ml

0.08

493

1037

Fever of other and unknown origin

2848

13169

2.01

238.59

1.4

1.3

244.78

249.94

u/ml

0.08

2644

12173

Allergic conjunctivitis

3344

17990

1.90

238.19

1.5

1.3

449.16

197.44

u/ml

7.97

3170

16597

Migraine

3004

12892

1.99

236.54

1.4

1.3

204.69

224.40

u/ml

0.23

2808

11902

Desensitization to allergens

624

1573

5.01

235.85

1.6

1.3

584.10

203.28

u/ml

3.31

605

1461

COPD, hospital admission 2, with asthma infections

1373

4528

2.75

235.55

1.5

1.3

322.96

257.01

u/ml

1.14

1285

4142

Early onset COPD

1174

4271

2.98

235.22

1.5

1.3

341.37

257.40

u/ml

1.30

1096

3935

Chronic diseases of tonsils and adenoids

3766

13293

1.86

234.72

1.3

1.2

275.29

216.39

u/ml

0.88

3521

12214

Eosinophilia

259

296

14.72

225.50

2.8

1.2

618.14

241.45

u/ml

1.78

250

274

General examination and investigation of persons without complaint and reported diagnosis

2965

7958

2.01

225.32

1.4

1.2

229.48

257.55

u/ml

0.62

2747

7346

Codeine

4802

15723

1.71

221.83

1.3

230.10

244.64

u/ml

0.35

4437

14577

Neurological diseases

4514

13383

1.75

220.79

1.3

237.01

271.46

u/ml

0.64

4185

12366

Emphysema

377

630

6.68

219.94

1.4

1.1

240.11

202.03

u/ml

0.46

350

565

COPD related to multimorbidity

1575

5648

2.48

218.35

1.4

1.3

328.44

254.52

u/ml

1.58

1472

5151

Symptoms and signs involving speech and voice

1781

8137

2.34

218.32

1.5

1.3

167.02

227.57

u/ml

2.21

1663

7479

Chronic laryngitis and laryngotracheitis

787

2396

3.61

215.38

1.5

1.2

210.82

183.34

u/ml

0.50

734

2197

Persons encountering health services for examination and investigation

3012

7962

1.96

210.67

1.3

1.2

230.56

257.45

u/ml

0.61

2801

7350

Asthma mixed form (mode), excluding more controls

347

566

6.97

208.26

1.5

1.1

261.60

182.72

u/ml

1.18

334

515

Soft tissue disorders

5146

16496

1.65

206.32

1.3

200.85

282.36

u/ml

5.95

4781

15244

Asthma mixed form (mode)

347

577

6.83

204.36

1.5

1.1

261.60

201.16

u/ml

0.75

334

527

Other headache syndromes

2264

11567

2.06

204.08

1.4

1.3

194.74

222.40

u/ml

0.45

2105

10685

Other intervertebral disc disorders

3924

13870

1.76

203.84

1.4

1.3

184.98

269.24

u/ml

5.48

3637

12862

Provisional assignment of new diseases of uncertain etiology

2729

14923

1.91

199.35

1.4

1.3

201.89

247.13

u/ml

1.92

2497

13808

Codes for special purposes

2730

14940

1.91

198.93

1.4

1.3

201.81

247.15

u/ml

1.93

2498

13824

Opioids

4967

16079

1.65

198.91

1.3

242.23

249.96

u/ml

0.16

4592

14894

Codeine or tramadol medication

5521

19445

1.60

195.51

1.3

226.80

246.29

u/ml

0.61

5100

18024

Dorsopathies

5107

16340

1.63

195.14

1.3

212.71

283.48

u/ml

4.05

4735

15118

Tramadol

3791

13751

1.75

193.99

1.4

1.3

232.67

241.49

u/ml

0.17

3497

12774

Other joint disorders

4580

14886

1.67

192.78

1.3

214.40

272.04

u/ml

2.73

4262

13782

Pain (limb, back, neck, head abdominally)

3470

9881

1.81

192.17

1.3

216.58

315.77

u/ml

4.72

3218

9140

Autoimmune diseases related-to ILD

4114

21720

1.67

189.28

1.4

1.3

225.95

251.61

u/ml

0.76

3822

20111

Other diseases of pleura

1811

7603

2.18

189.16

1.4

1.3

220.45

261.19

u/ml

1.22

1687

6957

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4716

20625

1.63

186.97

1.5

1.3

285.44

232.52

u/ml

1.50

4317

19179

Oedema, not elsewhere classified

1521

6827

2.32

185.98

1.4

1.3

272.26

236.07

u/ml

0.51

1425

6275

Other respiratory disorders and diseases

958

3537

2.90

185.52

1.5

1.3

179.62

244.47

u/ml

2.33

894

3246

Other diseases of the respiratory system

958

3537

2.90

185.52

1.5

1.3

179.62

244.47

u/ml

2.33

894

3246

Systemic connective tissue disorders

1770

8590

2.18

185.25

1.4

1.3

190.25

223.46

u/ml

0.85

1629

7894

Sciatica+with lumbago

2466

12258

1.93

184.70

1.3

210.91

260.49

u/ml

1.37

2285

11361

Vocal cord dysfunction

841

2607

3.13

180.60

1.5

1.2

132.32

202.47

u/ml

3.52

798

2424

Other diseases of intestines

5315

19740

1.57

178.25

1.3

186.30

269.81

u/ml

7.89

4943

18277

Irritable bowel syndrome

1569

7434

2.25

175.62

1.4

1.3

141.06

225.32

u/ml

4.47

1459

6848

Neurological diseases, wide definition

1769

4133

2.25

174.11

1.3

1.2

241.02

319.68

u/ml

1.27

1635

3823

Symptoms and signs involving the digestive system and abdomen

4760

15230

1.61

170.50

1.4

1.3

210.72

294.34

u/ml

5.12

4403

14081

Other disorders of lacrimal gland

1782

8983

2.10

168.35

1.4

1.3

228.13

207.74

u/ml

0.38

1640

8263

Polypectomy (DHB20)

467

1199

4.50

167.36

1.9

1.2

370.02

237.59

u/ml

1.54

457

1108

Disorders of lacrimal system

2090

11104

1.97

167.07

1.4

1.3

221.35

215.87

u/ml

0.09

1927

10221

Disorders of eyelid, lacrimal system and orbit

3985

19021

1.64

166.96

1.4

1.3

290.09

234.68

u/ml

0.97

3672

17635

Abdominal and pelvic pain

4725

15226

1.60

166.03

1.3

217.84

294.39

u/ml

4.10

4383

14077

Diseases of the eye and adnexa

4253

13348

1.64

165.56

1.3

328.06

218.25

u/ml

2.83

3963

12350

Spondylosis

2293

10162

1.91

164.20

1.4

1.3

196.93

283.58

u/ml

3.64

2124

9416

COPD, hospital admissions 3, with asthma pneumonia sepsis

1036

3548

2.62

162.98

1.6

1.3

318.58

257.39

u/ml

1.13

964

3240

Recurrent or chronic depression

2178

8154

1.96

162.84

1.3

201.20

240.98

u/ml

1.06

2013

7606

Neurotic, stress-related and somatoform disorders

4512

20501

1.59

162.26

1.4

1.3

255.61

241.39

u/ml

0.20

4157

19008

Anxiety disorders

4538

20560

1.59

162.21

1.4

1.3

254.67

241.52

u/ml

0.18

4180

19061

Bacterial pneumonia (organism specified)

1864

8672

2.03

162.12

1.7

1.2

253.95

240.26

u/ml

0.23

1719

7956

Depression or dysthymia

3166

10255

1.76

161.50

1.3

249.27

254.17

u/ml

0.07

2903

9543

Anxiety disorders, excluding more controls

4164

17260

1.62

160.51

1.4

1.3

264.46

229.73

u/ml

0.56

3837

16043

Spondylopathies

3388

12178

1.71

160.30

1.3

207.73

275.48

u/ml

2.79

3138

11280

Symptoms and signs involving the skin and subcutaneous tissue

3365

20282

1.68

160.01

1.4

1.3

276.05

227.12

u/ml

1.21

3130

18795

Infective dermatitis

636

2051

3.41

158.85

1.4

1.3

792.41

150.10

u/ml

7.71

599

1885

Dysphagia

1128

4847

2.46

158.56

1.4

1.3

192.03

245.99

u/ml

1.45

1037

4448

Shoulder lesions

3333

12181

1.71

156.84

1.3

169.13

269.25

u/ml

7.48

3107

11273

Other antidepressants

4806

16102

1.57

156.04

1.3

292.42

250.83

u/ml

0.73

4431

14930

Lumbar disc prolapse

2893

13121

1.75

154.06

1.4

1.3

174.52

269.21

u/ml

6.62

2686

12177

Other systemic involvement of connective tissue (FG)

1297

5912

2.29

153.85

1.4

1.3

181.62

201.36

u/ml

0.46

1175

5436

Diseases of the musculoskeletal system and connective tissue

2825

8112

1.80

153.22

1.3

215.44

308.32

u/ml

3.57

2638

7509

Other disorders of white blood cells

418

1062

4.64

153.11

2.3

1.3

514.99

216.93

u/ml

2.47

390

986

Respiratory insufficiency

311

606

5.49

152.08

1.4

1.1

172.97

270.59

u/ml

0.97

286

537

GASTRO-related operations

4123

13125

1.62

151.92

1.4

1.2

228.09

239.09

u/ml

0.21

3806

12155

Any gastric operation

4123

13125

1.62

151.92

1.4

1.2

228.09

239.09

u/ml

0.21

3806

12155

Lichen simplex chronicus and prurigo

419

1069

4.49

151.04

1.5

1.2

847.13

151.64

u/ml

3.82

398

977

Nerve, nerve root and plexus disorders

4841

19747

1.54

150.32

1.3

204.98

248.58

u/ml

2.14

4507

18291

Arthropathies

4535

14965

1.58

149.87

1.3

221.36

274.34

u/ml

2.28

4208

13858

Bacterial pneumoniae

1744

7927

2.02

149.00

1.7

1.2

248.85

237.88

u/ml

0.18

1608

7289

Other and unspecified immunodeficiencies with predominantly antibody defects

194

264

12.05

147.11

2.0

1.2

49.91

219.60

u/ml

1.23

149

242

Gastrointestinal diseases

3115

9344

1.72

144.52

1.3

1.2

210.80

271.91

u/ml

2.03

2892

8620

Diagnoses used for exclusion with ILD

1155

5226

2.33

144.02

1.5

1.3

222.14

241.86

u/ml

0.24

1055

4824

Nummular dermatitis

462

1302

3.95

143.32

1.4

1.3

493.23

159.45

u/ml

3.14

433

1190

Simple and mucopurulent chronic bronchitis

243

407

6.75

142.08

1.7

1.2

176.52

202.42

u/ml

0.15

231

364

Implicit viral Sepsis

1312

6273

2.20

142.05

1.4

1.3

209.62

223.76

u/ml

0.24

1200

5777

Diarrhoea and gastroenteritis of presumed infectious origin

4778

21252

1.52

141.33

1.4

1.3

244.07

248.96

u/ml

0.07

4438

19662

Persons encountering health services in other circumstances, wide

5454

19256

1.49

141.27

1.3

268.42

245.42

u/ml

0.62

5050

17814

Bacterial pneumonia, not elsewhere classified

1635

7400

2.02

140.94

1.7

1.2

251.98

238.30

u/ml

0.22

1510

6806

Infections, IBD-co-morbidities

759

1965

2.92

139.43

1.5

1.2

246.10

294.63

u/ml

0.59

683

1822

Myalgia

1260

6002

2.23

138.88

1.4

1.3

186.68

249.84

u/ml

1.42

1174

5521

Certain infectious and parasitic diseases

4762

15950

1.53

138.85

1.4

1.2

315.33

207.79

u/ml

3.22

4397

14753

Personal history of allergy to drugs, medicaments and biological substances

184

252

11.73

138.39

2.0

1.2

217.05

270.94

u/ml

0.23

177

236

Intestinal infectious diseases

5351

21074

1.48

137.96

1.3

236.59

254.25

u/ml

0.32

4967

19496

Prurigo nodularis

228

385

7.54

136.12

1.6

1.2

1002.36

153.13

u/ml

3.25

222

345

Follow-up examination after treatment for conditions other than malignant neoplasms

1897

6730

1.93

135.69

1.4

1.2

173.12

246.67

u/ml

3.36

1772

6212

Other systemic involvement of connective tissue

1322

6470

2.16

135.42

1.4

1.3

186.72

197.18

u/ml

0.21

1197

5923

Dentofacial anomalies [including malocclusion]

3621

18906

1.59

133.53

1.3

183.57

242.74

u/ml

3.42

3374

17496

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5145

19239

1.49

132.73

1.3

266.57

245.46

u/ml

0.52

4802

17801

Covid-19 confirmed case

1634

8679

1.97

131.45

1.4

1.3

218.22

250.24

u/ml

0.69

1500

8002

Viral Sepsis

950

4121

2.45

131.27

1.5

1.3

253.77

240.10

u/ml

0.13

871

3809

Implicit viral Sepsis

946

4108

2.44

130.39

1.5

1.3

223.92

240.56

u/ml

0.21

867

3797

Enlarged lymph nodes

838

3461

2.59

129.78

1.6

1.2

638.42

247.08

u/ml

1.90

767

3207

Persons encountering health services for specific procedures and health care

5107

21255

1.47

128.49

1.4

1.3

287.88

240.97

u/ml

1.01

4738

19678

Sleep disorders

4253

20736

1.52

128.45

1.3

232.88

242.00

u/ml

0.12

3924

19179

Insomnia

4197

20623

1.52

127.30

1.3

234.23

237.13

u/ml

0.04

3872

19082

Mycoses

3968

23156

1.53

126.66

1.4

1.3

280.36

242.92

u/ml

0.94

3659

21450

Pain, not elsewhere classified

1370

6950

2.07

126.45

1.4

1.2

164.62

236.17

u/ml

2.87

1267

6427

All influenza

1156

5518

2.20

125.78

1.6

1.2

250.78

243.63

u/ml

0.08

1078

5112

Autoimmune diseases excluding thyroid diseases

4841

18173

1.49

125.02

1.4

1.3

281.32

252.47

u/ml

0.72

4498

16847

Candidiasis

1484

7804

2.01

124.38

1.4

1.3

223.11

219.57

u/ml

0.04

1374

7176

Rotator cuff syndrome

2502

10781

1.72

123.98

1.3

183.09

277.18

u/ml

4.28

2332

9968

Kela reimbursement Agammaglobulinemia (D80-84)

150

187

14.52

123.62

2.2

1.2

81.26

252.18

u/ml

0.72

100

173

Temporomandibular joint disorders, including avohilmo

2427

14552

1.72

123.22

1.3

166.16

218.92

u/ml

2.67

2254

13427

Exposure to unspecified factor

4636

23067

1.48

123.15

1.4

1.3

271.90

246.01

u/ml

0.73

4308

21346

L04AX Other immunosuppressants

2654

16479

1.67

122.99

1.4

1.3

419.71

219.42

u/ml

4.32

2481

15256

Mycoses

1281

6427

2.10

122.72

1.7

1.3

443.07

228.99

u/ml

3.44

1194

5917

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

579

2066

3.12

122.43

1.6

1.3

287.17

204.36

u/ml

1.05

546

1900

Certain infectious and parasitic diseases

3453

11082

1.60

121.93

1.3

1.2

236.16

218.35

u/ml

0.44

3187

10240

187

286

8.00

121.63

2.0

1.2

336.72

160.32

u/ml

2.51

174

258

Behavioural syndromes associated with physiological disturbances and physical factors

4360

21222

1.49

120.32

1.3

233.97

246.05

u/ml

0.17

4026

19640

Allergic urticaria

570

2041

3.13

120.26

1.6

1.3

386.97

204.30

u/ml

2.14

539

1880

Autoimmune diseases excluding thyroid diseases, strict definition

4690

17704

1.48

119.99

1.4

1.3

283.66

256.35

u/ml

0.64

4357

16410

Second line medication for Crohn's disease

2719

17100

1.65

119.46

1.4

1.3

412.36

217.85

u/ml

4.27

2540

15825

Idiopathic urticaria

241

491

6.47

119.39

1.6

1.3

209.17

218.86

u/ml

0.06

235

449

D07AA Corticosteroids, weak (group I)

973

4472

2.35

118.74

1.6

1.3

1487.45

188.89

u/ml

14.47

918

4149

Migraine with aura

1391

7288

2.02

117.90

1.4

1.3

167.23

204.98

u/ml

1.11

1315

6719

Used for control exclusion in common control thyroid runs

4884

17143

1.47

117.81

1.3

283.30

258.42

u/ml

0.40

4510

15896

Drug-induced adrenocortical insufficiency

210

388

7.46

116.65

2.5

1.2

488.75

187.54

u/ml

0.88

199

359

Functional dyspepsia

1280

6534

2.06

116.46

1.4

1.3

210.14

233.24

u/ml

0.31

1185

6009

Depression

4501

21168

1.48

116.21

1.3

263.11

244.72

u/ml

0.27

4125

19676

Disorders of synovium and tendon

2392

12790

1.69

115.69

1.4

1.3

191.54

260.00

u/ml

3.14

2238

11818

Other/unspecified dorsalgia

1670

9215

1.87

115.12

1.4

1.3

183.52

262.73

u/ml

3.35

1556

8499

Other symptoms and signs involving the circulatory and respiratory systems

357

977

4.02

115.06

1.4

1.2

161.85

225.74

u/ml

0.94

331

898

Non-invasive ventilation

1122

4856

2.16

114.78

1.6

1.3

178.23

227.00

u/ml

1.74

1021

4533

Dermatitis due to ingested food

359

966

4.31

114.65

1.8

1.3

1314.82

194.09

u/ml

6.31

349

891

Other nutritional deficiencies

3199

19815

1.57

114.28

1.3

271.17

226.96

u/ml

0.94

2984

18361

Mood disorders

4744

21553

1.46

113.89

1.3

259.22

247.48

u/ml

0.17

4331

20026

Mood [affective] disorders

4735

21550

1.46

113.63

1.3

259.53

247.34

u/ml

0.18

4323

20023

Autoimmune diseases

5101

18320

1.45

112.85

1.4

1.3

283.56

252.02

u/ml

0.57

4700

16980

Unspecified chronic bronchitis

193

323

6.68

112.70

1.7

1.1

162.37

213.29

u/ml

0.26

180

286

Other heart diseases, wide

4384

18563

1.48

112.51

1.4

1.3

209.98

254.63

u/ml

1.83

4095

17245

Continuous positive airway pressure

847

3095

2.43

112.51

1.4

1.3

219.00

272.87

u/ml

1.03

795

2890

Complications of surgical and medical care, not elsewhere classified

4391

20901

1.47

112.43

1.4

1.3

274.58

234.89

u/ml

0.72

4089

19356

Diseases of the ear and mastoid process

5452

19566

1.43

112.39

1.4

1.3

232.48

249.59

u/ml

0.32

5039

18148

Cardiovascular diseases

3377

11870

1.58

112.15

1.4

1.3

225.67

261.13

u/ml

0.80

3163

10992

Viral infections characterized by skin and mucous membrane lesions

3961

23260

1.49

112.09

1.4

1.3

339.87

234.58

u/ml

2.25

3650

21552

Other arthrosis

2146

8792

1.74

111.94

1.3

206.64

276.52

u/ml

1.57

2007

8164

Complications of medical and surgical care

3207

19491

1.55

110.92

1.4

1.3

290.26

227.15

u/ml

1.01

2986

18029

Unspecified acute lower respiratory infection

760

3241

2.51

109.88

1.7

1.2

429.07

247.52

u/ml

1.74

707

3020

Malaise and fatigue

2094

10035

1.73

109.43

1.4

1.3

246.72

244.40

u/ml

0.03

1933

9265

Care involving use of rehabilitation procedures

2884

17188

1.59

109.35

1.4

1.3

263.71

241.15

u/ml

0.24

2686

15927

Idiopathic pulmonary fibrosis

359

1023

3.84

108.92

1.6

1.2

245.40

225.28

u/ml

0.15

331

928

Depression medications

1719

4734

1.90

108.90

1.3

269.79

268.26

u/ml

0.01

1590

4411

Bronchitis, not specified as acute or chronic

382

1129

3.64

108.83

1.6

1.1

270.49

210.08

u/ml

0.65

360

1026

Mood disorders, excluding more controls

4296

17783

1.48

108.65

1.3

262.80

232.27

u/ml

0.51

3920

16526

Disorders of thyroid, IBD co-morbidities

864

2649

2.40

108.40

1.4

1.2

159.41

255.09

u/ml

3.10

816

2471

Disorders of skin appendages

2358

14697

1.66

107.52

1.3

258.66

248.66

u/ml

0.17

2206

13561

Nonhereditary hypogammaglobulinemia

149

215

10.54

106.40

1.9

1.2

62.20

256.21

u/ml

1.09

109

198

Anaemias

1267

4220

2.05

106.10

1.4

1.3

268.66

237.56

u/ml

0.37

1167

3952

Childhood allergy (age < 16)

1009

4009

2.23

105.62

1.5

1.3

950.30

193.20

u/ml

7.52

951

3652

Oxicams

921

2316

2.34

105.03

1.3

174.34

327.59

u/ml

3.62

851

2137

Hypothyroidism, strict autoimmune

3324

14563

1.54

104.81

1.3

208.16

228.78

u/ml

0.27

3053

13480

Diaphragmatic hernia

1439

7896

1.90

104.32

1.3

205.49

224.35

u/ml

0.27

1333

7240

Other immunodeficiencies

157

246

9.70

104.25

2.2

1.2

315.76

225.27

u/ml

0.28

151

225

Finngen Rheumatological endpoints

4456

17799

1.46

104.24

1.3

217.15

254.48

u/ml

1.52

4123

16548

Other enthesopathies

1372

7431

1.93

104.09

1.3

208.43

255.05

u/ml

0.98

1275

6876

Cardiovascular diseases (excluding rheumatic etc)

3421

13193

1.53

102.55

1.4

1.3

218.61

248.38

u/ml

0.70

3199

12270

Migraine, single triptan purchase ok & required. ICD-code if available is included

3801

17756

1.49

102.11

1.3

197.75

247.37

u/ml

0.99

3543

16409

Triptan medication for migraine, single purchase ok

3801

17756

1.49

102.11

1.3

197.75

247.37

u/ml

0.99

3543

16409

Factors influencing health status and contact with health services

1206

2980

2.09

101.85

1.3

1.2

265.65

309.43

u/ml

0.44

1116

2757

Other complications of surgical and medical care, not elsewhere classified

572

2226

2.81

101.79

1.6

1.3

311.74

203.33

u/ml

1.03

539

2057

Cervicobrachial syndrome

1057

5321

2.09

100.16

1.3

230.93

242.89

u/ml

0.09

965

4906

Cardiac arrhythmias

3003

12869

1.56

99.68

1.3

190.25

238.78

u/ml

1.65

2800

11994

Other and unspecified drugs and medicaments

515

1927

2.96

99.60

1.6

1.3

296.79

210.79

u/ml

0.96

487

1782

Antihypertensive medication - note that there are other indications

3301

11679

1.54

99.37

1.3

233.43

255.47

u/ml

0.40

3071

10826

Percutaneous Coronary Intervention

3143

12810

1.54

98.59

1.4

1.3

185.40

266.50

u/ml

7.19

2913

11879

Fibromyalgia

572

2266

2.77

98.43

1.4

1.3

107.43

186.07

u/ml

3.44

533

2093

Other disorders of skin and subcutaneous tissue

2831

16601

1.56

98.09

1.4

1.3

264.90

234.41

u/ml

0.72

2612

15358

Later onset COPD

823

2953

2.30

97.97

1.3

294.91

273.51

u/ml

0.29

772

2665

COPD-related respiratory insufficiency

460

1619

3.03

97.52

1.6

1.3

280.12

262.03

u/ml

0.17

437

1476

All anxiety disorders

3119

16586

1.53

97.46

1.4

1.3

288.69

236.45

u/ml

0.67

2867

15421

Adrenocortical insufficiency

288

782

4.38

96.90

2.3

1.2

475.19

206.52

u/ml

1.11

274

719

Persons encountering health services in other circumstances

1885

11350

1.71

96.75

1.4

1.3

251.48

244.45

u/ml

0.09

1723

10469

Coxibs

1145

2995

2.08

96.26

1.3

215.19

379.70

u/ml

3.92

1054

2756

Viral pneumonia

623

2584

2.57

95.75

1.6

1.2

279.23

202.16

u/ml

0.83

568

2384

Coronary revascularization (ANGIO or CABG)

3130

12816

1.53

95.49

1.4

1.3

184.71

266.41

u/ml

7.28

2901

11884

Symptoms and signs involving the nervous and musculoskeletal systems

2477

16041

1.59

95.46

1.4

1.3

200.70

242.77

u/ml

1.36

2292

14843

Polyarthropathies

2851

12252

1.56

95.01

1.3

245.95

263.29

u/ml

0.33

2622

11376

Other functional intestinal disorders

1912

10783

1.70

94.92

1.4

1.3

161.62

256.06

u/ml

5.93

1783

9927

Implicit Sepsis

3019

15251

1.53

94.82

1.4

1.3

253.04

247.33

u/ml

0.08

2781

14105

Somatoform disorder

878

4234

2.21

94.57

1.5

1.3

165.80

189.50

u/ml

0.47

811

3915

Implicit bacterial Sepsis

1585

7889

1.79

94.29

1.4

1.3

300.88

247.11

u/ml

0.78

1454

7256

Implicit fungal Sepsis

377

1223

3.41

93.96

1.6

1.3

297.25

205.34

u/ml

0.74

343

1135

Obesity and other hyperalimentation

2969

19319

1.52

93.87

1.3

265.96

227.93

u/ml

0.73

2771

17905

Other heart diseases

2365

9786

1.63

93.84

1.4

1.3

230.89

246.22

u/ml

0.25

2204

9120

Emergency coronary revascularization (for ACS)

3284

13532

1.51

93.49

1.4

1.3

196.05

265.02

u/ml

4.04

3041

12533

Cervical disc disorders

1434

8120

1.83

93.41

1.4

1.3

168.15

278.92

u/ml

5.40

1333

7505

Hypothyroidism and >3 levothyroxin purchases

1433

4450

1.89

92.88

1.4

1.3

234.66

248.95

u/ml

0.07

1326

4157

Hypothyroidism, levothyroxine purchases

1433

4450

1.89

92.88

1.4

1.3

234.66

248.95

u/ml

0.07

1326

4157

Selective deficiency of immunoglobulin G [IgG] subclasses

116

149

13.37

92.83

1.8

1.2

86.94

292.55

u/ml

0.73

106

141

Obesity

2951

19273

1.52

92.28

1.3

266.74

228.23

u/ml

0.74

2757

17861

Disorders of the thyroid gland

4175

19380

1.43

92.26

1.3

186.57

248.10

u/ml

1.67

3854

17972

ILD-related respiratory insufficiency

206

446

5.37

92.05

1.6

1.2

247.12

224.30

u/ml

0.17

189

404

Hypothyroidism (congenital or acquired)

1436

4474

1.88

91.82

1.4

1.3

231.69

248.29

u/ml

0.09

1330

4180

Dental caries

1074

5363

2.01

91.64

1.5

1.3

285.77

254.45

u/ml

0.37

989

4988

Anxiety (asthma-related co-morbidities)

3049

15993

1.52

91.48

1.4

1.3

291.03

234.25

u/ml

0.73

2807

14922

Hypertensive diseases (excluding secondary)

2544

9534

1.60

91.29

1.3

247.87

232.78

u/ml

0.21

2381

8891

Selective serotonin reuptake inhibitors

4359

16246

1.43

91.15

1.3

301.24

251.64

u/ml

0.82

4008

15070

Intestinal infectious diseases

4198

22900

1.42

90.52

1.4

1.3

250.89

246.56

u/ml

0.05

3884

21191

Disease of hard tissues of teeth, NOS

2292

7515

1.64

90.00

1.3

217.07

252.87

u/ml

0.83

2108

6969

Other noninfective gastroenteritis and colitis

1155

6208

1.95

89.99

1.5

1.3

301.20

228.77

u/ml

1.20

1066

5729

Implicit bacterial Sepsis

1428

7187

1.81

89.85

1.4

1.3

304.75

250.03

u/ml

0.70

1305

6602

Spinal stenosis

1724

7777

1.73

89.70

1.4

1.3

211.63

269.14

u/ml

2.01

1574

7171

Other anxiety disorders

2374

13356

1.59

89.45

1.4

1.3

261.06

238.49

u/ml

0.32

2178

12383

ILD medications: azathioprine

688

3074

2.37

88.94

1.3

1.2

188.97

175.71

u/ml

0.19

639

2815

Aspergillosis

111

139

11.94

88.84

4.6

1.2

1282.33

197.75

u/ml

2.48

106

125

Migraine without aura

1156

6271

1.95

88.51

1.4

1.3

263.20

197.54

u/ml

0.33

1083

5784

Other bacterial diseases

4393

20170

1.41

88.39

1.4

1.3

384.12

219.67

u/ml

5.78

4052

18716

Caries of dentine

953

4687

2.06

88.24

1.5

1.3

281.28

265.98

u/ml

0.15

878

4349

Complications of procedures, not elsewhere classified

3456

20033

1.46

87.68

1.4

1.3

275.49

229.98

u/ml

0.67

3212

18546

Ischemic heart diseases

3300

13636

1.49

87.13

1.4

1.3

179.70

267.49

u/ml

7.46

3061

12648

Other disorders of adrenal gland

326

1027

3.65

86.85

2.2

1.3

441.54

220.94

u/ml

1.00

311

945

Dermatitis due to substances taken internally

323

1004

3.58

86.52

1.6

1.3

511.32

134.17

u/ml

3.91

302

920

Hypothyroidism, other/unspecified

3924

18416

1.43

86.47

1.3

192.39

238.46

u/ml

0.99

3622

17062

Other general symptoms and signs

362

1202

3.35

85.91

1.6

1.3

142.02

240.70

u/ml

2.46

349

1119

Concussion

2194

11500

1.60

84.78

1.3

245.69

271.98

u/ml

0.40

2031

10636

Other diseases of blood and blood-forming organs, wide

972

5044

2.03

84.65

1.8

1.3

332.95

223.19

u/ml

1.62

883

4659

Hypothyreosis and Thyroxine purchase for inclusion criteria

4051

19157

1.42

84.12

1.3

193.00

234.03

u/ml

0.87

3744

17742

Cervicalgia

894

4513

2.07

83.82

1.4

1.3

181.17

224.29

u/ml

1.11

828

4148

Soft tissue disorders related to use, overuse and pressure

1096

5928

1.92

83.33

1.3

271.77

245.86

u/ml

0.29

1019

5449

Pain in thoracic spine

731

3441

2.25

83.24

1.4

1.3

138.57

218.99

u/ml

3.13

678

3176

Diverticular disease of intestine

2673

11384

1.53

83.00

1.3

226.26

250.38

u/ml

0.46

2474

10538

Noninfective enteritis and colitis

2076

13335

1.60

82.93

1.4

1.3

254.03

257.33

u/ml

0.04

1922

12335

Implicit Sepsis

3336

17090

1.46

82.59

1.4

1.3

240.28

244.91

u/ml

0.07

3077

15839

Symptoms and signs involving cognition, perception, emotional state and behaviour

4162

20636

1.40

82.26

1.4

1.3

201.97

250.18

u/ml

1.96

3852

19124

Azathioprine

688

3177

2.29

82.14

1.3

1.2

188.97

179.32

u/ml

0.13

639

2909

Bacterial Sepsis

1639

8456

1.70

82.13

1.4

1.3

294.93

256.32

u/ml

0.51

1492

7783

Sarcoidosis

644

2927

2.35

80.68

1.4

1.3

160.73

216.28

u/ml

0.65

594

2712

Congenital malformations of trachea and bronchus

119

181

9.52

80.55

2.1

1.3

96.95

280.48

u/ml

0.75

108

162

Heart failure, not strict

2756

12687

1.51

80.24

1.3

272.08

244.10

u/ml

0.61

2553

11720

Exfoliative dermatitis

104

133

10.18

80.03

2.0

1.2

3585.76

221.61

u/ml

5.51

117

Major coronary heart disease event

3222

13539

1.47

79.94

1.4

1.3

188.09

262.85

u/ml

6.48

2981

12556

Other disorders of urethra and urinary system

3044

15266

1.47

79.13

1.4

1.3

209.06

226.45

u/ml

0.36

2813

14084

Dizziness and giddiness

3102

17193

1.46

78.95

1.3

182.47

246.50

u/ml

3.86

2854

15917

Obesity due to excess calories

2190

14440

1.57

78.58

1.3

278.58

224.26

u/ml

0.90

2050

13365

Disturbances of skin sensation

1337

7834

1.78

78.42

1.4

1.3

229.65

220.86

u/ml

0.08

1256

7243

Rheumatism, unspecified

638

2921

2.32

78.12

1.4

1.3

124.44

191.18

u/ml

2.74

592

2674

Other symptoms and signs involving the nervous and musculoskeletal systems

1840

11688

1.63

77.78

1.4

1.3

179.46

237.11

u/ml

2.83

1707

10802

Arthrosis

2844

10621

1.50

77.71

1.3

209.80

259.18

u/ml

1.61

2640

9863

Dyshidrosis [pompholyx]

154

308

6.31

77.19

1.3

1.2

349.66

156.60

u/ml

2.33

145

283

Pain and other conditions associated with female genital organs and menstrual cycle

1160

6018

1.86

77.08

1.3

177.20

207.03

u/ml

0.61

1077

5576

Other arrhythmias

2741

14185

1.49

76.82

1.3

159.88

249.69

u/ml

6.36

2527

13173

Migraine with aura and triptan purchases

936

4984

2.00

76.67

1.4

1.3

149.07

191.91

u/ml

1.38

889

4612

Diarrhoea and gastroenteritis of presumed infectious origin

3101

19708

1.45

76.57

1.4

1.3

245.90

251.53

u/ml

0.06

2880

18216

Other diseases of hard tissues of teeth

2290

7710

1.57

76.21

1.3

231.11

251.58

u/ml

0.41

2107

7149

Hypertension, essential

3355

13425

1.45

75.92

1.3

256.13

224.61

u/ml

0.67

3137

12470

Visual disturbances

2020

13174

1.58

75.86

1.4

1.3

237.93

234.78

u/ml

0.04

1864

12137

Constipation

3636

18209

1.41

74.44

1.4

1.3

177.47

254.18

u/ml

5.21

3344

16894

Disorders of other endocrine glands

1931

12328

1.59

74.05

1.5

1.3

226.89

231.51

u/ml

0.06

1790

11366

Triptan medication for migraine, min. 3 purchases

2922

15667

1.46

73.28

1.3

185.93

213.28

u/ml

0.34

2736

14526

Internal derangement of knee

1523

9318

1.68

73.18

1.3

246.73

274.66

u/ml

0.38

1422

8638

Other and unspecified rosacea

474

1977

2.61

73.18

1.3

195.07

189.14

u/ml

0.06

454

1832

Visual disturbances and blindness

2117

14054

1.55

72.89

1.4

1.3

239.40

237.83

u/ml

0.02

1955

12953

Endocrine, nutritional and metabolic diseases

3833

14084

1.41

72.81

1.4

1.3

253.07

252.42

u/ml

0.01

3538

13072

Other bacterial diseases

3842

18926

1.39

72.29

1.5

1.3

398.07

224.46

u/ml

5.28

3532

17564

L04AA Selective immunosuppressants

1050

5890

1.87

71.94

1.5

1.3

511.06

224.72

u/ml

2.08

980

5460

Seborrhoeic dermatitis

416

1633

2.72

71.93

1.3

176.80

162.96

u/ml

0.16

377

1496

Atypical mycobacterium lung infection

109

167

8.38

71.65

2.0

1.2

167.06

279.37

u/ml

0.36

102

153

Polyarthrosis

760

3542

2.08

71.26

1.4

1.2

157.17

222.56

u/ml

2.12

696

3243

Pulmonary eosinophilia, not elsewhere classified

118

199

7.74

71.12

2.6

1.2

390.86

227.30

u/ml

0.98

111

180

Osteopathies and chondropathies

2231

13992

1.52

71.03

1.4

1.3

276.84

232.39

u/ml

0.45

2078

12914

Hard cardiovascular diseases

3330

14208

1.43

71.02

1.4

1.3

188.99

257.75

u/ml

5.13

3092

13194

Viral infections characterized by skin and mucous membrane lesions

1799

11616

1.60

70.55

1.5

1.3

524.13

228.96

u/ml

3.71

1663

10737

Bacterial infection, other or unspecified

2098

11767

1.54

70.37

1.4

1.3

305.82

226.48

u/ml

1.91

1921

10867

Other diseases of lip and oral mucosa

1696

10831

1.62

70.26

1.3

217.87

238.72

u/ml

0.29

1565

10000

Infection due to other mycobacteria

129

237

6.65

70.25

2.0

1.2

149.08

287.51

u/ml

0.71

121

220

Rosacea

597

2790

2.29

70.20

1.4

1.3

192.19

184.68

u/ml

0.10

568

2578

Covid-19 suspected case

1128

6513

1.82

70.10

1.4

1.3

172.31

227.11

u/ml

1.53

1030

6032

Congenital malformations of the respiratory system

180

445

5.07

70.03

1.9

1.4

115.15

194.84

u/ml

0.76

168

404

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2422

16431

1.49

69.92

1.4

1.3

295.82

223.27

u/ml

0.86

2242

15173

Other external causes of accidental injury

3713

13513

1.40

69.69

1.3

259.96

235.41

u/ml

0.34

3446

12488

Acetic acid derivatives and related substances

1041

2908

1.91

69.49

1.3

180.24

361.75

u/ml

5.62

954

2680

Cystitis

3728

16224

1.39

69.40

1.3

211.46

231.52

u/ml

0.48

3448

14981

Infections of the skin and subcutaneous tissue

2497

17148

1.48

69.02

1.4

1.3

470.08

237.95

u/ml

6.52

2350

15863

Papulosquamous disorders

1597

10111

1.63

68.53

1.4

1.3

362.35

230.78

u/ml

3.24

1495

9325

Carpal tunnel syndrome

2481

15118

1.48

68.50

1.3

203.67

233.52

u/ml

0.83

2308

13978

Meniscus derangement

2096

9389

1.54

66.96

1.3

202.73

274.68

u/ml

2.94

1936

8717

Diseases of middle ear and mastoid

2652

15234

1.46

66.84

1.4

1.3

300.67

243.56

u/ml

0.68

2463

14072

Inflammatory diseases of female pelvic organs

2936

15416

1.44

66.63

1.3

210.74

189.39

u/ml

0.23

2710

14241

Dental operations

2301

7926

1.52

66.49

1.3

213.42

276.16

u/ml

2.07

2113

7354

Intracranial trauma

2424

11717

1.49

66.11

1.3

250.67

271.77

u/ml

0.32

2240

10836

Syncope and collapse

1617

8798

1.61

65.85

1.3

248.35

255.12

u/ml

0.09

1489

8110

Hypothyroidism, strict autoimmune, 3 medication purchases required

3632

18106

1.38

65.67

1.3

203.27

228.76

u/ml

0.39

3333

16761

Enthesopathies of lower limb, excluding foot

946

5276

1.87

65.51

1.4

1.3

183.91

256.73

u/ml

1.52

884

4868

Herpesviral [herpes simplex] infections

1200

7182

1.74

65.31

1.4

1.3

552.13

187.40

u/ml

2.93

1109

6644

Special screening examination for infectious and parasitic diseases

1112

4719

1.79

64.83

1.3

1.2

213.91

237.17

u/ml

0.40

1006

4365

Other diseases of urinary system

4277

18124

1.35

64.81

1.3

221.28

245.06

u/ml

0.62

3951

16788

Heart failure and antihypertensive medication

904

3174

1.93

64.81

1.3

278.05

232.09

u/ml

0.54

834

2921

Deforming dorsopathies

1151

6821

1.75

64.21

1.3

189.48

264.07

u/ml

1.81

1059

6276

Nausea and vomiting

1076

6125

1.78

64.04

1.4

1.3

205.63

282.21

u/ml

1.24

996

5621

Lung cancer and mesothelioma

412

1424

2.54

63.44

1.2

1.1

268.30

265.03

u/ml

0.02

377

1273

Bacterial infection, other or unspecified

1863

10713

1.54

63.06

1.5

1.3

298.77

231.10

u/ml

1.50

1696

9875

Condition for Implicit Sepsis (Organ dysfunction codes)

3704

19041

1.37

62.71

1.4

1.3

235.05

247.05

u/ml

0.22

3423

17661

Mouth breathing

1612

10428

1.59

62.68

1.4

1.3

246.21

259.51

u/ml

0.16

1505

9700

Gonarthrosis

2372

9285

1.48

62.26

1.3

202.81

269.15

u/ml

2.11

2191

8618

Pulmonary heart disease, diseases of pulmonary circulation

1090

6410

1.75

62.14

1.4

1.3

212.37

240.31

u/ml

0.47

1010

5862

Congenital malformations of the respiratory system

162

409

4.95

61.36

2.0

1.4

116.01

203.55

u/ml

0.78

151

372

Accidents

3641

13513

1.37

60.53

1.3

260.28

235.41

u/ml

0.34

3378

12488

Occupational exposure to risk-factors

207

615

3.83

60.30

1.5

1.2

218.58

243.27

u/ml

0.12

191

565

Oter anti-inflammatory and antirheumatic agents, non-steroids

712

1957

2.06

60.28

1.3

192.95

348.57

u/ml

2.80

653

1802

Injuries to the ankle and foot

3196

20987

1.38

60.18

1.3

253.50

246.15

u/ml

0.11

2981

19439

Haemorrhoids and perianal venous thrombosis

1130

6751

1.72

60.16

1.3

208.04

237.51

u/ml

0.49

1043

6188

Psychiatric diseases

4210

15985

1.34

59.92

1.3

273.01

236.47

u/ml

0.61

3868

14876

Hypertensive diseases

3374

14033

1.38

59.79

1.3

241.83

224.68

u/ml

0.34

3153

13039

Bullous disorders

284

1015

3.05

59.66

1.4

1.2

596.26

217.26

u/ml

4.36

268

928

Conjunctivitis (acute, non atopic)

1256

7745

1.68

59.62

1.4

1.3

394.87

198.09

u/ml

4.41

1167

7166

Migraine without aura and triptan purchases

926

5311

1.84

59.50

1.4

1.3

261.54

202.60

u/ml

0.23

866

4926

Suppurative and unspecified otitis media

1760

10386

1.55

59.44

1.4

1.3

324.51

243.80

u/ml

0.68

1634

9584

Hypertension

3369

14020

1.38

59.42

1.3

242.15

224.80

u/ml

0.34

3148

13026

Any mental disorder

4693

18118

1.32

59.18

1.3

283.66

232.32

u/ml

1.08

4305

16844

Dental pulpitis, including avohilmo

4130

20469

1.33

59.10

1.3

222.67

250.47

u/ml

0.82

3831

18991

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2226

15546

1.46

58.88

1.4

1.3

291.51

226.23

u/ml

0.68

2059

14347

Osteoporosis

890

4681

1.84

58.84

1.5

1.3

214.76

204.10

u/ml

0.15

820

4233

Condition for Implicit Sepsis (Organ dysfunction codes)

3382

17749

1.37

58.55

1.4

1.3

242.95

244.83

u/ml

0.03

3125

16455

Other specified/unspecified arthritis

1073

6412

1.73

58.02

1.4

1.3

231.38

270.74

u/ml

0.46

996

5917

Artrosis, including avohilmo

3365

13611

1.38

57.90

1.3

210.65

252.39

u/ml

1.42

3130

12658

Other skin changes

713

3788

1.97

57.82

1.4

1.3

334.67

219.43

u/ml

0.87

653

3469

Other contact dermatitis

381

1594

2.55

57.81

1.4

1.3

561.09

137.13

u/ml

2.77

357

1469

Diseases of oral cavity, salivary glands and jaws

2198

7737

1.49

57.54

1.3

209.04

251.24

u/ml

1.32

2027

7173

Injury, poisoning and certain other consequences of external causes

2458

8636

1.45

56.80

1.3

217.03

225.41

u/ml

0.15

2288

7961

Pemphigoid

150

371

4.58

56.52

1.3

1.2

585.14

178.40

u/ml

4.02

141

335

Candidiasis

629

3245

2.05

56.29

1.5

1.3

248.00

191.24

u/ml

0.67

584

2991

Fenamates

584

1924

2.14

56.21

1.3

167.05

305.09

u/ml

2.52

538

1776

Other reaction to severe stress, and adjustment disorders

1731

11663

1.53

56.19

1.4

1.3

207.90

218.26

u/ml

0.18

1607

10821

Other necrotizing vasculopathies (FG)

267

954

3.02

55.80

1.5

1.2

174.89

214.84

u/ml

0.44

250

873

Benign neoplasm: Colon

1764

11365

1.51

55.57

1.4

1.3

232.69

245.12

u/ml

0.15

1611

10491

Subjective visual disturbances

1057

6387

1.72

55.24

1.3

176.44

194.62

u/ml

0.37

971

5872

Other viral diseases

1790

12100

1.51

55.01

1.4

1.3

276.03

254.05

u/ml

0.25

1649

11224

Other gastritis (incl. Duodenitis)

784

4354

1.86

54.79

1.4

1.3

284.54

259.96

u/ml

0.27

720

3997

External causes of morbidity and mortality

2951

10768

1.40

54.75

1.3

228.04

229.91

u/ml

0.03

2733

9927

Trochanteric bursitis

570

2865

2.08

54.47

1.3

158.16

201.24

u/ml

1.03

523

2616

Chronic gastritis

880

5070

1.79

54.03

1.3

189.78

248.44

u/ml

1.33

811

4632

Rash and other nonspecific skin eruption

457

2133

2.28

53.84

1.5

1.3

421.69

205.40

u/ml

1.99

429

1971

Other arthritis (FG)

1242

7849

1.63

53.76

1.4

1.3

239.66

252.92

u/ml

0.14

1154

7251

Injuries to the knee and lower leg

5047

22130

1.28

53.71

1.4

1.3

231.41

252.73

u/ml

0.68

4701

20450

Impingement syndrome of shoulder

889

5157

1.78

53.67

1.3

144.84

246.61

u/ml

6.03

832

4757

Implicit fungal Sepsis

206

654

3.50

53.63

1.9

1.3

347.61

219.05

u/ml

0.71

188

605

Paracetamol or NSAID medication

722

1884

1.98

53.60

1.3

235.46

417.59

u/ml

2.21

664

1743

Fungal Sepsis

216

705

3.39

53.59

1.9

1.3

355.53

220.41

u/ml

0.80

197

652

Sulfasalazine

1020

6140

1.71

53.40

1.3

1.2

148.09

174.39

u/ml

0.59

949

5602

Menorrhagia

1558

5639

1.58

53.29

1.3

146.60

195.59

u/ml

1.87

1451

5217

Septicaemia

1403

8509

1.58

53.21

1.4

1.3

342.89

235.64

u/ml

2.20

1275

7832

Abnormal findings on examination of blood, without diagnosis

1583

9679

1.54

53.01

1.4

1.3

325.58

265.74

u/ml

0.56

1480

8952

Cervicocranial syndrome

463

2180

2.24

52.90

1.4

1.3

148.43

212.05

u/ml

1.51

430

2015

Benign neoplasm of colon, rectum, anus and anal canal

2106

12852

1.45

52.88

1.3

219.72

242.26

u/ml

0.37

1926

11877

Exclusions for E4_PCOS_BROAD

806

4594

1.84

52.46

1.7

1.3

309.31

228.43

u/ml

0.62

752

4267

Other necrotizing vasculopathies

310

1236

2.69

52.32

1.5

1.2

209.20

206.45

u/ml

0.02

291

1138

Bullous pemphigoid

119

261

5.21

52.30

1.4

1.2

519.95

182.34

u/ml

3.48

112

236

Acute suppurative otitis media

1339

8088

1.60

52.29

1.5

1.3

315.46

250.09

u/ml

0.38

1237

7471

Tonsillectomy and adenotomy

2826

14513

1.39

52.23

1.4

1.3

279.67

233.43

u/ml

0.50

2642

13482

L04AD Calcineurin inhibitors

529

2655

2.12

51.62

1.5

1.3

702.15

235.83

u/ml

2.75

493

2470

Diseases of the digestive system

1609

10788

1.52

51.49

1.4

1.3

301.51

253.12

u/ml

0.61

1490

9933

Exposure to other specified factors

3191

22154

1.35

51.46

1.4

1.3

266.63

248.01

u/ml

0.35

2979

20501

Other inflammation of eyelid

577

2978

2.04

51.41

1.5

1.3

298.24

210.90

u/ml

1.13

550

2741

Hernia of abdominal wall, postoperative

674

3649

1.91

51.20

1.3

1.2

210.77

225.96

u/ml

0.18

629

3388

Diseases of salivary glands

1330

8647

1.59

51.14

1.3

234.14

220.41

u/ml

0.18

1220

7971

Heart failure,strict

1581

7413

1.54

51.09

1.3

287.94

266.42

u/ml

0.31

1463

6778

Benign neoplasms

4211

18042

1.31

50.99

1.3

182.09

272.67

u/ml

8.35

3897

16704

Sicca syndrome [Sjögren]

411

1888

2.33

50.64

1.3

1.2

135.26

174.34

u/ml

0.72

363

1733

Gonarthrosis [arthrosis of knee](FG)

2764

11787

1.39

50.48

1.3

203.23

257.16

u/ml

1.88

2554

10968

Vasomotor rhinitis (mode)

356

1543

2.49

50.42

1.5

1.2

204.73

198.54

u/ml

0.03

332

1424

Excessive, frequent and irregular menstruation

1851

6945

1.50

50.12

1.3

154.41

211.54

u/ml

3.00

1723

6403

Explicit Sepsis

1519

9479

1.53

50.10

1.4

1.3

338.05

252.37

u/ml

1.43

1383

8728

Reimbursement for rheumatic diseases

2279

16400

1.41

50.07

1.3

157.81

234.12

u/ml

6.00

2103

15170

Pleural plaque

288

1125

2.68

49.90

1.3

314.44

332.19

u/ml

0.08

267

1007

Gout

752

3702

1.83

49.77

1.3

436.24

304.02

u/ml

1.42

680

3419

Erysipelas

2597

14543

1.39

49.68

1.4

1.3

497.07

219.09

u/ml

6.90

2402

13479

Other symptoms and signs involving the digestive system and abdomen

688

3793

1.89

49.67

1.4

1.3

184.03

214.66

u/ml

0.49

644

3472

Propionic acid derivatives

1091

3303

1.70

49.65

1.3

253.71

384.36

u/ml

2.33

1013

3048

Other septicaemia

1226

7553

1.60

49.30

1.5

1.3

363.08

227.61

u/ml

2.69

1120

6940

Heartburn

468

2275

2.16

49.17

1.3

1.2

121.79

226.48

u/ml

4.63

439

2099

Methotrexate

521

2630

2.06

48.98

1.3

1.2

168.80

157.16

u/ml

0.14

480

2395

Pulmonary embolism

974

5926

1.69

48.97

1.4

1.3

201.97

244.96

u/ml

0.79

898

5426

Other epidermal thickening

233

842

3.04

48.30

1.3

1.2

283.20

235.29

u/ml

0.31

222

772

Pulmonary heart disease

974

5947

1.68

48.30

1.4

1.3

201.97

244.48

u/ml

0.78

898

5447

Herpesviral [herpes simplex] infections

543

2811

2.04

48.26

1.6

1.3

1036.67

194.77

u/ml

3.18

499

2603

Symptoms and signs concerning food and fluid intake

434

2063

2.21

48.11

1.5

1.2

377.10

251.09

u/ml

0.38

408

1899

Caries of enamel

3832

21535

1.31

48.09

1.3

247.55

244.10

u/ml

0.06

3524

19976

Nonorganic sleeping disorders, excluding more controls

888

5321

1.73

48.08

1.3

176.60

202.77

u/ml

0.46

821

4932

Hypothyroidism, drug reimbursement

689

2664

1.90

47.75

1.3

141.03

223.57

u/ml

3.05

637

2501

Allergic contact dermatitis due to drugs in contact with skin

154

446

4.01

47.15

1.5

1.2

578.27

208.14

u/ml

1.79

147

409

Lateral epicondylitis

575

3051

1.97

47.12

1.3

185.32

208.73

u/ml

0.30

543

2822

Bleeding

2978

15981

1.35

46.84

1.4

1.3

250.32

264.92

u/ml

0.25

2760

14781

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1966

8754

1.45

46.49

1.3

163.50

230.64

u/ml

3.09

1827

8154

Anti-inflammatory and antirheumatic products, non-steroids

1076

3305

1.67

46.38

1.3

236.27

384.26

u/ml

3.03

997

3050

Other sleep disorders

454

2232

2.13

46.25

1.4

1.3

439.07

230.99

u/ml

0.45

424

2057

Budesonide

538

2807

2.00

46.10

1.4

1.2

188.55

165.69

u/ml

0.28

498

2567

Genitourinary diseases

2452

8941

1.40

45.95

1.3

316.55

299.33

u/ml

0.21

2269

8319

Endometriosis

1572

6240

1.52

45.79

1.3

151.74

196.29

u/ml

1.69

1446

5775

Nonsuppurative otitis media

1113

6153

1.62

45.52

1.5

1.3

305.97

265.50

u/ml

0.44

1026

5641

Collagenous colitis

412

1976

2.22

45.37

1.6

1.3

260.47

180.35

u/ml

0.90

383

1824

1148

6767

1.59

45.09

1.3

237.49

246.04

u/ml

0.08

1051

6152

DVT of lower extremities and pulmonary embolism

1354

9014

1.53

45.08

1.4

1.3

208.04

243.00

u/ml

0.74

1252

8267

Other diseases of anus and rectum

1017

6372

1.63

44.99

1.3

234.90

249.20

u/ml

0.10

936

5848

Spondylolisthesis/Spondylolysis

669

3767

1.84

44.96

1.4

1.3

190.36

248.11

u/ml

1.02

623

3456

Other bacterial intestinal infections

861

5201

1.71

44.87

1.5

1.3

256.42

228.33

u/ml

0.38

785

4781

Erysipelas

1857

11654

1.44

44.42

1.4

1.3

558.17

229.80

u/ml

5.51

1710

10780

Acute pharyngitis

700

3988

1.81

44.21

1.4

1.2

269.95

246.87

u/ml

0.20

660

3686

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4056

20886

1.28

44.17

1.4

1.3

203.53

253.87

u/ml

2.82

3742

19386

Disorders of sclera, cornea, iris and ciliary body

2137

15619

1.40

43.92

1.4

1.3

413.32

223.29

u/ml

2.67

1971

14453

Acute generalized exanthematous pustulosis

243

946

2.82

43.77

1.6

1.3

374.04

205.36

u/ml

1.19

228

866

Polyneuropathies and other disorders of the peripheral nervous system

723

4194

1.78

43.76

1.4

1.3

276.27

253.12

u/ml

0.17

672

3861

5-aminosalicylic acid

784

4648

1.74

43.74

1.3

1.2

247.89

181.23

u/ml

0.73

729

4261

Congenital malformations, deformations and chromosomal abnormalities

2836

19908

1.34

43.71

1.4

1.3

222.65

247.96

u/ml

0.45

2634

18448

Abnormal results of function studies

391

1865

2.22

43.60

1.3

140.16

235.58

u/ml

2.54

363

1718

Zoster [herpes zoster]

1732

12037

1.45

43.45

1.4

1.3

264.45

218.97

u/ml

0.84

1582

11068

Non-selective monoamine reuptake inhibitors

1351

8770

1.52

43.31

1.3

221.10

223.60

u/ml

0.02

1243

8094

Missing teeth due to accident, extraction or parodontitis

2022

13806

1.41

43.23

1.3

234.64

244.85

u/ml

0.15

1835

12771

All influenza (not pneumonia)

591

3247

1.89

43.19

1.5

1.2

272.39

216.84

u/ml

0.76

547

3005

Other viral diseases, not elsewhere classified

1235

8168

1.55

43.05

1.4

1.3

272.63

240.66

u/ml

0.35

1141

7584

Generalized skin eruption due to drugs and medicaments

222

834

2.94

43.04

1.6

1.2

395.12

210.36

u/ml

1.20

209

765

Paroxysmal tachycardia

912

4697

1.68

42.98

1.4

1.3

167.73

238.20

u/ml

2.85

850

4344

Other disorders of patella

755

4477

1.75

42.56

1.3

238.69

252.84

u/ml

0.09

707

4153

Other and unspecified tonsillitis

1485

8586

1.49

42.30

1.4

1.2

267.16

241.45

u/ml

0.30

1381

7935

Radiculopathy

541

2907

1.93

42.18

1.4

1.3

149.67

243.17

u/ml

3.05

501

2672

Hypermobility syndrome

335

1538

2.38

42.15

1.5

1.3

139.77

175.64

u/ml

0.66

313

1440

Congenital malformations, deformations and chromosomal abnormalities

2596

18730

1.35

41.87

1.4

1.3

217.02

250.04

u/ml

0.66

2410

17328

Common variable immunodeficiency

121

7.91

41.71

2.1

1.2

98.06

308.20

u/ml

0.52

108

Any death

993

10997

0.63

41.33

1.3

438.39

247.58

u/ml

1.08

893

10133

Metabolic disorders

3712

17841

1.29

41.30

1.4

1.3

223.85

246.48

u/ml

0.66

3435

16557

Pneumonia due to other infectious organisms, not elsewhere classified

169

557

3.33

41.26

2.1

1.2

321.86

208.60

u/ml

0.44

157

514

Xerosis cutis

106

259

4.80

41.21

1.2

229.81

251.31

u/ml

0.07

101

238

Venous thromboembolism

1785

12368

1.42

40.63

1.4

1.3

201.58

246.09

u/ml

1.33

1642

11403

Any operation in hilmo

171

252

3.59

40.48

1.3

1.1

370.87

196.60

u/ml

0.63

157

225

Persons with potential health hazards related to communicable diseases

1795

12836

1.42

40.42

1.4

1.3

245.46

252.05

u/ml

0.09

1676

11885

Injuries to the wrist and hand

4149

23060

1.26

40.40

1.3

271.52

245.26

u/ml

0.49

3851

21351

Excessive attrition of teeth

2376

17895

1.36

40.35

1.3

208.96

241.70

u/ml

0.75

2205

16601

Chronic kidney disease

858

5200

1.66

40.31

1.4

1.3

372.41

261.36

u/ml

1.18

797

4774

Other disorders involving the immune mechanism, not elsewhere classified

180

627

3.20

40.30

2.3

1.3

546.32

237.61

u/ml

0.85

162

582

Other and unspecified polyneuropathies, also in other diseases

624

3556

1.82

40.27

1.4

1.3

290.68

261.31

u/ml

0.19

583

3258

Diseases of pulp and periapical tissues and dental caries

2488

9496

1.36

40.17

1.3

217.52

239.48

u/ml

0.53

2281

8830

Heart failure, strict

1658

8227

1.45

40.11

1.3

285.87

266.52

u/ml

0.29

1533

7512

Other diseases of oesophagus

340

1580

2.25

40.05

1.5

1.2

274.93

238.29

u/ml

0.15

322

1437

Disorders of vestibular function (Vertigo)

1638

11436

1.44

39.98

1.3

163.84

236.21

u/ml

3.28

1510

10525

Dental caries, including avohilmo

2774

10751

1.34

39.98

1.3

222.56

238.66

u/ml

0.38

2558

10001

Unspecified privation

456

2373

2.02

39.87

1.5

1.3

361.11

217.63

u/ml

1.92

438

2190

Other disorders of fluid, electrolyte and acid-base balance

981

5989

1.60

39.48

1.4

1.3

349.28

238.07

u/ml

1.27

905

5489

Other disorders of ear

3516

18158

1.29

39.21

1.3

203.27

257.29

u/ml

2.17

3237

16850

Other shoulder lesions

403

2020

2.10

39.15

1.3

1.2

202.90

220.93

u/ml

0.18

371

1855

Noninfectious colitis NAS

571

3207

1.86

39.14

1.5

1.3

246.72

197.86

u/ml

0.60

524

2955

Use of hypnotics and sedatives

4233

19540

1.26

39.12

1.4

1.3

248.54

236.96

u/ml

0.16

3899

18168

Falls/tendency to fall

4712

19148

1.25

39.07

1.3

243.58

251.48

u/ml

0.15

4365

17723

Atrial fibrillation and flutter

1130

4794

1.56

39.05

1.3

262.51

253.58

u/ml

0.08

1059

4462

Irregular menses

2313

13734

1.36

38.86

1.4

1.3

208.97

191.71

u/ml

0.15

2157

12706

Psoriasis vulgaris

721

4327

1.73

38.86

1.4

1.3

335.53

221.18

u/ml

1.67

679

4006

Diseases of pulp and periapical tissues, including avohilmo

4363

18209

1.26

38.84

1.3

259.12

244.53

u/ml

0.29

4001

16887

Polyarteritis nodosa and related conditions

100

245

4.79

38.79

2.1

1.2

270.18

250.57

u/ml

0.06

224

Psoriasis

1079

7122

1.56

38.77

1.3

353.88

228.53

u/ml

2.47

1018

6581

Rheumatoid arthritis

1106

6547

1.55

38.74

1.3

166.49

247.76

u/ml

2.73

1029

6035

Skin changes due to chronic exposure to nonionizing radiation

1031

6179

1.57

38.71

1.3

221.41

249.30

u/ml

0.33

943

5606

Fibroblastic disorders

728

4368

1.71

38.71

1.3

185.77

255.73

u/ml

1.38

677

4001

Other enthesopathy of foot (+metatarsalgia)

428

2207

2.03

38.35

1.3

194.52

202.32

u/ml

0.08

389

2023

Viral and other specified intestinal infections

1275

8412

1.50

38.33

1.4

1.3

218.81

271.88

u/ml

1.02

1181

7754

Caries of dentine, including avohilmo

3029

11946

1.31

38.19

1.3

230.84

238.26

u/ml

0.15

2794

11100

Angina pectoris

1690

8010

1.43

38.19

1.4

1.3

206.54

273.16

u/ml

1.85

1554

7370

Actinic keratosis

990

5924

1.58

38.12

1.3

225.01

252.95

u/ml

0.31

906

5376

Brachial plexus disorders

464

2476

1.98

37.96

1.3

150.45

211.09

u/ml

1.36

437

2305

Atrial fibrillation and flutter with reimbursement

839

3275

1.67

37.81

1.3

261.07

251.18

u/ml

0.08

778

3028

Renal failure

1309

7936

1.49

37.67

1.3

346.36

256.98

u/ml

1.35

1210

7284

Other bacterial intestinal infections

644

3775

1.76

37.67

1.5

1.3

269.58

211.88

u/ml

0.83

588

3470

All-cause Heart Failure

1615

8081

1.43

37.51

1.3

289.42

268.02

u/ml

0.32

1493

7375

Pleural plaque with presence of asbestos

212

825

2.70

37.22

1.3

331.00

302.04

u/ml

0.12

195

735

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1368

9463

1.47

36.89

1.4

1.3

284.79

212.09

u/ml

0.46

1261

8774

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

290

1311

2.33

36.80

1.4

1.3

302.64

215.72

u/ml

0.99

272

1199

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

167

588

3.17

36.73

2.4

1.3

576.26

243.08

u/ml

0.86

151

546

Obesity, other/unspecified

1463

10382

1.45

36.32

1.3

235.73

221.33

u/ml

0.16

1369

9622

Other viral diseases

1302

9026

1.48

36.24

1.4

1.3

289.13

254.09

u/ml

0.33

1200

8366

Sequelae of external causes of morbidity and mortality

908

5874

1.59

35.76

1.4

1.3

325.82

223.26

u/ml

0.45

847

5405

Acute laryngitis and tracheitis

575

3273

1.80

35.56

1.6

1.2

318.72

274.28

u/ml

0.34

541

3034

Coxarthrosis

1545

7231

1.43

35.52

1.3

308.66

264.73

u/ml

0.43

1408

6697

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1210

8329

1.49

35.48

1.3

188.25

259.13

u/ml

2.14

1130

7730

Bacterial intestinal infections, IBD co-morbidities

643

3831

1.73

35.46

1.5

1.3

272.39

204.11

u/ml

1.06

586

3532

Chronic apical periodontitis

4568

21319

1.23

35.37

1.3

272.01

239.30

u/ml

0.72

4178

19790

Presence of other functional implants

1824

9245

1.39

35.36

1.3

251.47

253.64

u/ml

0.03

1653

8546

Diseases of inner ear

1863

13329

1.38

35.28

1.3

162.52

235.73

u/ml

4.10

1718

12297

Other disorders of skin and subcutaneous tissue, not elsewhere classified

523

2951

1.84

35.17

1.4

1.3

331.50

212.49

u/ml

0.89

475

2714

Transport accidents

1874

11916

1.38

35.14

1.3

234.01

235.90

u/ml

0.03

1747

10999

Polycystic ovarian syndrome, consortium definition

3229

15137

1.29

35.06

1.3

205.75

193.15

u/ml

0.14

2994

13957

Other and unspecified nerve root and plexus disorders, also in other diseases

757

4730

1.65

34.77

1.5

1.3

168.57

232.08

u/ml

1.96

697

4386

Hyperkinetic disorders, excluding more controls

616

3501

1.76

34.75

1.4

1.3

273.83

252.90

u/ml

0.18

569

3247

Viral pneumonia (known virus, not influenza)

134

428

3.46

34.67

1.6

1.3

347.31

263.99

u/ml

0.26

118

389

Benzodiazepine use

3994

22343

1.25

34.59

1.3

249.73

242.77

u/ml

0.09

3662

20736

Diseases of external ear

1243

8638

1.47

34.47

1.4

1.3

339.73

257.19

u/ml

0.90

1145

7968

Neoplasms

3482

14710

1.27

34.42

1.4

1.3

260.97

262.56

u/ml

0.02

3224

13655

Other and unspecified anaemias

1257

8316

1.47

34.39

1.4

1.3

452.91

228.09

u/ml

2.90

1147

7627

Dermatophytosis

2282

17447

1.33

34.38

1.3

281.97

250.95

u/ml

0.49

2096

16152

Other disorders of eyelid

1367

9178

1.44

34.37

1.3

317.13

224.07

u/ml

0.61

1240

8415

Gingivitis and periodontal diseases

4086

17100

1.25

34.28

1.3

266.39

239.75

u/ml

0.42

3758

15853

Post-traumatic stress disorder

463

2554

1.92

34.27

1.4

1.3

158.53

200.81

u/ml

1.19

417

2379

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1670

12189

1.40

34.04

1.4

1.3

289.64

250.57

u/ml

0.39

1539

11283

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1210

8396

1.48

33.91

1.4

1.3

307.77

253.91

u/ml

0.69

1126

7770

Other medical care

1498

9670

1.42

33.79

1.4

1.3

425.07

244.09

u/ml

3.34

1385

8884

Speech therapy

929

6127

1.56

33.55

1.4

1.3

172.39

224.06

u/ml

1.74

873

5621

Other anaemias

1265

8398

1.46

33.50

1.4

1.3

452.56

227.57

u/ml

2.94

1155

7703

Cystic fibrosis with pulmonary manifestations

29.53

33.49

3.7

1.2

113.68

976.06

u/ml

0.55

Superficial injury of lower leg

1000

6705

1.53

33.46

1.3

231.91

248.44

u/ml

0.17

930

6176

Lichen simplex chronicus

155

548

3.07

33.41

1.5

1.2

387.08

165.68

u/ml

1.31

142

498

Other pulmonary heart/vessel disease

177

669

2.82

33.36

1.5

1.2

276.05

254.81

u/ml

0.11

169

608

Disorders of gallbladder, biliary tract and pancreas

3744

19101

1.25

33.30

1.4

1.3

204.00

242.92

u/ml

1.71

3480

17691

Hypersensitivity pneumonitis due to organic dust

101

278

4.17

33.29

1.8

1.2

139.07

163.45

u/ml

0.18

247

ILD medications: pirfenidone

104

6.61

33.29

1.2

1.1

191.29

123.91

u/ml

0.77

Benign paroxysmal vertigo

1004

6740

1.53

33.28

1.3

147.15

218.25

u/ml

4.84

915

6169

Dislocation, sprain and strain of joints and ligaments at neck level

687

4251

1.68

33.24

1.4

1.3

229.03

217.12

u/ml

0.11

631

3953

Conduction disorders

895

4712

1.57

33.22

1.3

250.93

269.17

u/ml

0.19

825

4329

Lichen planus, including avohilmo

673

4136

1.68

33.13

1.3

290.81

199.94

u/ml

1.34

616

3794

Viral pneumonia (unknown virus, not influenza)

292

1386

2.23

33.08

1.5

1.3

181.51

217.55

u/ml

0.46

267

1273

Hernia

3555

19214

1.26

32.94

1.3

253.02

243.99

u/ml

0.13

3294

17787

Lichen ruber planus, wide definition including periferal and oral lichen planus

786

5024

1.61

32.83

1.3

261.23

203.57

u/ml

0.85

725

4611

Ovarian cyst

1573

6537

1.42

32.79

1.3

169.83

201.88

u/ml

0.84

1452

6048

Type of accident

1118

7694

1.49

32.76

1.4

1.3

299.28

253.69

u/ml

0.52

1040

7114

Metatarsalgia

385

2024

1.99

32.67

1.3

177.10

203.75

u/ml

0.33

351

1855

Ganglion

840

5455

1.59

32.64

1.3

205.38

226.01

u/ml

0.26

785

5034

Nonorganic sleeping disorders

888

5850

1.57

32.60

1.3

176.60

218.00

u/ml

0.81

821

5409

Other and unspecified iron deficiency

1164

8066

1.47

32.57

1.4

1.3

242.81

228.44

u/ml

0.19

1069

7413

Hyperlipidaemia, other/unspecified

1139

7218

1.48

32.48

1.3

224.08

261.38

u/ml

0.77

1045

6629

Gout, FINNGEN

752

4736

1.62

32.48

1.3

436.24

295.43

u/ml

1.59

680

4346

Aplastic and other anaemias

1365

9059

1.43

32.38

1.4

1.3

438.00

237.97

u/ml

2.70

1243

8323

Cellulitis

817

5287

1.59

32.26

1.4

1.3

293.16

222.78

u/ml

1.44

769

4886

Osteoporosis with pathological fracture (FG)

242

1073

2.37

32.18

1.6

1.2

213.70

155.30

u/ml

0.65

222

973

Other and unspecified vasculitis limited to skin

131

434

3.36

32.06

1.6

1.2

257.15

282.87

u/ml

0.10

125

394

Ischaemic heart disease, wide definition

2510

12048

1.31

32.00

1.4

1.3

223.03

260.87

u/ml

1.13

2306

11166

Universal erythroderma, KELA reimbursement

221

4.51

32.00

1.9

1.3

3320.79

215.84

u/ml

3.86

196

Melanocytic naevi

1174

8201

1.47

31.89

1.3

176.50

230.56

u/ml

1.43

1104

7569

Adhesive capsulitis of shoulder

568

3373

1.74

31.76

1.3

194.11

216.76

u/ml

0.23

528

3086

Other menopausal disorders

1125

4319

1.51

31.73

1.3

114.46

187.61

u/ml

4.54

1037

3996

Zoster [herpes zoster]

610

3695

1.70

31.65

1.5

1.3

345.69

210.26

u/ml

1.48

553

3396

Iron deficiency anaemia

1438

10245

1.41

31.57

1.4

1.3

235.18

223.55

u/ml

0.18

1322

9417

ILD medications: nintedanib

9.24

31.49

1.3

1.1

167.94

118.99

u/ml

0.51

Otitis externa

871

5752

1.56

31.48

1.4

1.3

317.35

233.22

u/ml

0.69

801

5322

Unspecified/other endometriosis

478

2734

1.84

31.29

1.4

1.3

132.97

192.03

u/ml

1.95

439

2537

Recurrent aphthous stomatitis , including avohilmo

577

3469

1.73

31.18

1.3

146.59

218.11

u/ml

2.52

534

3203

Injuries to the neck

929

6236

1.53

31.06

1.4

1.3

214.71

231.49

u/ml

0.23

854

5784

Other and unspecified follicular disorders

203

855

2.57

31.04

1.5

1.3

330.29

241.58

u/ml

0.52

195

791

Other disorders of veins

1500

10907

1.40

30.99

1.3

196.25

228.33

u/ml

0.71

1398

10078

Inflammatory bowel disease

1241

8801

1.44

30.91

1.3

199.33

251.12

u/ml

0.90

1149

8173

Gonarthrosis,primary

2998

14706

1.27

30.64

1.3

225.68

252.44

u/ml

0.52

2755

13658

Cholecystectomy

2575

17488

1.29

30.55

1.4

1.3

190.40

227.04

u/ml

1.66

2391

16183

Personality disorders, excluding more controls

1098

7634

1.48

30.54

1.3

278.34

221.13

u/ml

0.26

995

7105

Heart failure and coronary heart disease

1072

5187

1.49

30.48

1.3

240.17

291.90

u/ml

1.15

1001

4744

Disorders of ocular muscles, binocular movement, accommodation and refraction

1952

14757

1.34

30.47

1.4

1.3

216.40

246.16

u/ml

0.69

1792

13647

Flat foot [pes planus] (acquired)

371

1974

1.96

30.36

1.4

1.2

183.19

200.28

u/ml

0.13

333

1825

Disorders of lens

2220

10650

1.32

30.21

1.4

1.3

305.05

229.16

u/ml

1.89

2031

9894

Lung diseases due to external agents

415

2284

1.87

30.11

1.5

1.3

270.65

236.92

u/ml

0.24

370

2083

Other follicular disorders

337

1749

2.04

30.08

1.5

1.3

355.95

211.52

u/ml

1.19

320

1620

Symptoms and signs involving the urinary system

2654

15975

1.28

30.00

1.3

219.42

252.87

u/ml

0.97

2452

14781

Dermatophytosis

467

2675

1.81

29.99

1.4

1.3

545.89

215.92

u/ml

2.22

435

2449

Other specified/unspecified systemic involvement of connective tissue

273

1318

2.21

29.95

1.4

1.2

208.62

183.84

u/ml

0.20

249

1207

Generalized anxiety disorder

759

4927

1.60

29.95

1.4

1.3

266.17

212.06

u/ml

0.47

701

4562

Plantar fascial fibromatosis

386

2091

1.93

29.90

1.2

1.3

106.85

202.80

u/ml

4.89

354

1921

Secondary right heart disease

157

592

2.83

29.79

1.5

1.2

301.21

269.59

u/ml

0.14

149

535

Otalgia

362

1933

1.98

29.69

1.4

1.3

163.29

231.45

u/ml

1.32

329

1788

Intracranial injury

2140

15652

1.31

29.63

1.3

245.43

263.93

u/ml

0.26

1966

14459

Endometriosis of pelvic peritoneum

740

4557

1.60

29.60

1.3

128.41

191.67

u/ml

2.06

677

4233

Cholelithiasis

3106

17231

1.26

29.55

1.4

1.3

188.14

230.54

u/ml

1.89

2890

15950

Non-ischemic cardiomyopathy

845

4477

1.55

29.54

1.3

327.93

247.21

u/ml

1.01

780

4086

Fissure and fistula of anal and rectal regions

850

5651

1.54

29.53

1.3

163.49

249.66

u/ml

2.97

791

5222

Open wound of lower leg

557

3363

1.71

29.44

1.5

1.3

262.17

244.40

u/ml

0.19

522

3094

Other extrapyramidal and movement disorders in other diseases

803

5283

1.56

29.42

1.3

141.96

228.65

u/ml

5.61

744

4846

Stomatitis and related lesions

782

5126

1.57

29.38

1.3

222.53

218.39

u/ml

0.03

728

4739

Disorders of muscles

381

2070

1.92

29.14

1.3

1.2

168.15

230.54

u/ml

1.30

357

1899

Vasculitis limited to skin, not elsewhere classified

137

492

3.07

29.03

1.6

1.2

286.53

278.23

u/ml

0.03

131

447

Other diseases of liver

672

4267

1.63

29.02

1.4

1.3

316.19

220.03

u/ml

0.81

634

3955

Nutritional anaemias

1621

11660

1.36

29.02

1.4

1.3

299.04

228.12

u/ml

0.97

1494

10724

Hallux valgus (acquired)

1172

5930

1.45

28.89

1.3

180.65

232.77

u/ml

0.76

1084

5463

Atopic conjunctivitis

233

1075

2.33

28.82

1.5

1.2

903.51

187.94

u/ml

0.97

216

996

Abnormal findings on diagnostic imaging of other body structures

483

2826

1.77

28.76

1.4

1.3

172.92

206.52

u/ml

0.68

431

2599

Striking against or struck by other objects

1293

9347

1.41

28.65

1.4

1.3

324.53

289.04

u/ml

0.31

1203

8675

Heart failure and bmi 25plus

983

4514

1.50

28.59

1.3

263.89

270.65

u/ml

0.06

905

4147

Pneumocystosis

101

308

3.69

28.45

2.1

1.2

175.63

264.63

u/ml

0.47

280

Other viral diseases, not elsewhere classified

789

5206

1.56

28.43

1.4

1.3

282.73

245.56

u/ml

0.31

731

4843

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

773

5101

1.57

28.42

1.3

191.46

181.88

u/ml

0.07

718

4708

Gout, idiopatic and unspecified

649

4098

1.62

28.25

1.3

461.68

263.32

u/ml

2.33

591

3765

Cholelithiasis, broad definition with cholecystitis

3205

17504

1.25

28.16

1.4

1.3

191.22

232.92

u/ml

1.89

2980

16209

Other disorders of bone

787

5214

1.56

28.11

1.4

1.3

337.46

228.48

u/ml

0.40

746

4840

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3565

18733

1.23

27.89

1.3

203.53

246.70

u/ml

2.02

3295

17395

Other/unspecified synovitis and tenosynovitis

423

2407

1.82

27.77

1.4

1.3

169.22

222.44

u/ml

0.87

401

2203

Otitis media, unspecified

553

3118

1.70

27.76

1.4

1.3

250.80

275.73

u/ml

0.20

515

2871

Contact with and exposure to communicable diseases

1466

10846

1.38

27.73

1.4

1.3

219.63

239.65

u/ml

0.30

1359

10042

567

3499

1.68

27.70

1.5

1.3

200.95

205.06

u/ml

0.04

515

3238

Keratitis

1316

9601

1.40

27.69

1.4

1.3

551.63

219.75

u/ml

3.15

1204

8863

Inflammatory disease of uterus

661

4244

1.62

27.62

1.4

1.3

135.88

173.07

u/ml

1.11

605

3921

Allergic colitis

174

730

2.69

27.59

1.8

1.3

659.07

316.61

u/ml

1.24

164

674

Primary_lymphoid and hematopoietic malignant neoplasms

719

4680

1.57

27.55

1.5

1.3

494.72

248.30

u/ml

0.87

609

4319

Mixed connective tissue disease

291

1485

2.08

27.45

1.4

1.3

184.98

179.13

u/ml

0.04

262

1362

Scabies

640

4084

1.63

27.38

1.4

1.3

370.24

238.22

u/ml

0.84

592

3774

Peritonsillar abscess

708

4599

1.58

27.37

1.3

1.2

256.95

212.00

u/ml

0.44

645

4242

Lichen planus

452

2639

1.78

27.22

1.3

322.36

190.98

u/ml

1.46

419

2420

Acute bronchiolitis

338

1633

1.98

27.13

1.6

1.3

417.99

371.61

u/ml

0.23

312

1512

Coronary atherosclerosis

1908

9226

1.33

27.12

1.3

237.21

277.06

u/ml

0.86

1749

8521

Other diseases of intestine

448

2605

1.77

27.10

1.4

1.3

315.01

256.83

u/ml

0.22

422

2395

Sensorineural hearing loss

2448

13138

1.28

27.08

1.3

210.30

256.34

u/ml

1.34

2243

12159

Injuries to the thorax

1449

10756

1.37

26.96

1.3

274.33

257.27

u/ml

0.19

1338

9930

Sequelae with surgical and medical care as external cause

678

4385

1.59

26.93

1.4

1.3

345.48

221.91

u/ml

0.40

636

4033

Benign neoplasm: Colon, unspecified

735

4835

1.56

26.84

1.4

1.3

260.51

242.71

u/ml

0.20

668

4421

Coeliac disease

507

3073

1.72

26.72

1.4

1.3

225.03

209.76

u/ml

0.16

470

2843

Cluster headache, wide

187

811

2.47

26.69

1.3

140.52

229.35

u/ml

1.24

176

752

Ocular pain

375

2095

1.88

26.67

1.4

1.3

223.15

201.91

u/ml

0.11

350

1937

Acute renal failure

606

3820

1.62

26.66

1.4

1.3

360.85

257.32

u/ml

0.80

557

3492

Panic disorder

688

4488

1.59

26.61

1.3

383.74

207.43

u/ml

0.59

631

4169

Postviral fatigue syndrome

214

4.48

26.57

1.5

1.2

135.50

131.38

u/ml

0.03

192

Other disorders of eye and adnexa

582

3658

1.65

26.48

1.3

221.24

206.59

u/ml

0.11

544

3392

Disorders of vitreous body

1581

11519

1.35

26.46

1.3

143.86

239.42

u/ml

9.91

1454

10604

Senile cataract

1904

8939

1.32

26.45

1.4

1.3

301.70

230.81

u/ml

1.51

1727

8274

Coagulation defects, purpura and other haemorrhagic conditions

718

4729

1.56

26.36

1.4

1.3

235.63

219.38

u/ml

0.19

650

4366

Other and unspecified disorders of vitreous body

1331

9671

1.38

26.22

1.3

134.92

217.50

u/ml

8.16

1224

8882

Cluster headache, strict

179

769

2.50

26.17

1.3

144.86

234.15

u/ml

1.17

168

718

Restless leg syndrome

495

2995

1.71

26.17

1.3

156.77

203.08

u/ml

1.16

460

2768

Other hammer toe(s) (acquired)

515

2884

1.69

26.15

1.4

1.2

244.31

215.82

u/ml

0.17

486

2628

Conductive and sensorineural hearing loss

2641

14274

1.26

26.12

1.3

209.23

259.32

u/ml

1.57

2425

13220

Tinnitus

805

5444

1.52

25.92

1.4

1.3

203.37

249.84

u/ml

0.58

733

5020

Pain associated with micturition

445

2627

1.76

25.82

1.3

188.22

207.43

u/ml

0.17

411

2431

Localized swelling, mass and lump of skin and subcutaneous tissue

1109

7959

1.42

25.81

1.4

1.3

261.31

237.33

u/ml

0.28

1031

7327

Cutaneous abscess, furuncle and carbuncle

980

6889

1.46

25.78

1.4

1.3

326.41

235.38

u/ml

1.52

921

6387

Cardiac murmurs and other cardiac sounds

350

1901

1.89

25.78

1.4

1.2

269.88

246.05

u/ml

0.09

319

1753

Other diseases of pericardium

169

709

2.53

25.75

1.5

1.3

166.28

258.86

u/ml

1.16

163

658

Oxycodone

1092

7041

1.43

25.73

1.4

1.3

250.13

238.76

u/ml

0.10

993

6501

Hypo-osmolality and hyponatraemia

519

3166

1.67

25.59

1.3

460.26

233.09

u/ml

1.53

471

2888

Seropositive rheumatoid arthritis

816

5519

1.51

25.58

1.3

155.51

215.70

u/ml

2.47

756

5074

Benign neoplasm of other and ill-defined parts of digestive system

586

3714

1.63

25.49

1.5

1.3

198.85

207.88

u/ml

0.09

548

3415

Other and unspecified local infections of skin and subcutaneous tissue

373

2107

1.85

25.34

1.5

1.3

680.56

206.44

u/ml

2.00

347

1945

Gastroduodenal ulcer

667

4330

1.56

25.32

1.3

349.88

265.65

u/ml

0.49

625

3960

Disorders of vitreous body and globe

1613

11798

1.33

25.23

1.3

142.39

241.15

u/ml

10.70

1484

10867

Pediculosis, acariasis and other infestations

707

4695

1.56

25.20

1.4

1.3

348.16

238.40

u/ml

0.74

654

4340

Mental and behavioural disorders due to tobacco

353

1969

1.88

25.15

1.4

1.3

418.59

226.41

u/ml

1.79

334

1815

All kidney diseases

3876

22161

1.21

25.14

1.4

1.3

266.75

233.51

u/ml

0.89

3572

20539

Artificial joint operation, meniscal resection

3110

16522

1.24

25.11

1.3

220.83

255.85

u/ml

1.03

2848

15336

Melanocytic naevi, other sites/unspecified

345

1914

1.89

25.10

1.2

1.3

120.14

213.07

u/ml

2.32

324

1770

Smoking dependency

353

1971

1.88

25.07

1.4

1.3

418.59

225.73

u/ml

1.80

334

1817

Valvular heart disease excluding rheumatic fever

1409

7557

1.37

25.00

1.3

226.78

270.38

u/ml

0.95

1287

6974

Coxarthrosis [arthrosis of hip](FG)

1646

8794

1.33

25.00

1.3

299.92

251.24

u/ml

0.53

1498

8157

Polyuria

684

4503

1.56

24.96

1.3

249.90

254.94

u/ml

0.04

631

4155

Viral and other specified intestinal infections

916

6247

1.47

24.91

1.4

1.3

249.07

285.53

u/ml

0.41

845

5766

Non-rheumatic valve diseases

1391

7446

1.37

24.87

1.3

229.06

270.97

u/ml

0.88

1269

6870

Other CVD (FINNGEN)

341

1437

1.89

24.74

1.4

1.2

320.89

249.12

u/ml

0.31

316

1316

Fall on same level

4713

21869

1.19

24.59

1.3

259.49

247.33

u/ml

0.25

4388

20243

Hernia of abdominal wall

1486

11243

1.34

24.53

1.3

262.83

251.07

u/ml

0.13

1394

10378

Transplanted organ and tissue status

375

2144

1.82

24.48

1.5

1.3

304.25

254.45

u/ml

0.29

345

1991

Noninflammatory disorders of female genital tract

1837

7089

1.32

24.42

1.3

164.19

214.40

u/ml

2.12

1697

6537

Extrapyramidal and movement disorders

1158

8450

1.40

24.27

1.3

189.35

233.36

u/ml

0.66

1071

7738

Diseases of tongue

218

1041

2.19

24.26

1.5

1.2

231.58

214.79

u/ml

0.11

203

958

All chronic kidney diseases

1723

10865

1.31

23.97

1.4

1.3

336.39

256.07

u/ml

1.12

1587

10026

Pneumonia due to Streptococcus pneumoniae

168

727

2.45

23.94

1.6

1.2

202.39

200.23

u/ml

0.02

152

670

Viral warts

856

5965

1.47

23.81

1.4

1.3

367.13

221.34

u/ml

0.63

786

5527

Respiratory disorders in diseases classified elsewhere

252

3.75

23.73

1.6

1.2

149.00

242.47

u/ml

0.42

224

Diseases of liver

1142

8351

1.39

23.73

1.4

1.3

292.25

248.83

u/ml

0.49

1064

7710

Other/unspecified enthesopathies of lower limb, excluding foot

281

1484

1.98

23.71

1.4

1.3

112.61

236.95

u/ml

4.27

267

1375

Liquid cancers, helper endpoint

1181

7547

1.39

23.67

1.5

1.3

373.39

240.21

u/ml

0.78

1046

6982

Umbilical hernia

900

6325

1.45

23.65

1.3

256.71

256.62

u/ml

0.00

849

5876

Achilles tendinitis

357

2031

1.82

23.54

1.4

1.3

237.42

204.14

u/ml

0.27

332

1877

Disorders of parathyroid gland

622

4013

1.57

23.53

1.3

172.37

206.01

u/ml

0.53

576

3657

Suppurative and necrotic conditions of lower respiratory tract

196

911

2.26

23.49

1.4

1.3

418.29

254.31

u/ml

0.44

182

834

Other local infections of skin and subcutaneous tissue

383

2229

1.79

23.46

1.4

1.3

684.73

202.54

u/ml

2.13

356

2052

Adenomyosis (Endometriosis of uterus)

504

3149

1.65

23.45

1.3

138.09

206.88

u/ml

2.79

470

2885

Disorders of lipoprotein metabolism and other lipidaemias

2782

14028

1.24

23.43

1.3

236.07

252.43

u/ml

0.32

2562

12995

Other cataract

1310

7367

1.37

23.43

1.4

1.3

299.79

229.88

u/ml

1.39

1208

6797

Diseases of arteries, arterioles and capillaries (FINNGEN)

742

3443

1.52

23.36

1.3

321.08

258.50

u/ml

0.89

681

3183

Use of pramipexole

695

4666

1.53

23.22

1.4

1.3

217.31

218.22

u/ml

0.01

643

4269

Other bursopathies

412

2449

1.73

23.11

1.3

270.23

236.40

u/ml

0.26

389

2239

Disturbance of activity and attention

612

3945

1.58

23.04

1.4

1.3

329.58

280.65

u/ml

0.31

566

3665

Selective deficiency of immunoglobulin A [IgA]y

6.36

23.01

1.6

1.2

154.39

352.63

u/ml

0.36

Abnormal involuntary movements

484

3010

1.66

22.96

1.4

1.3

247.09

214.21

u/ml

0.18

452

2770

Other congenital malformations

421

2539

1.74

22.95

1.5

1.3

199.63

226.95

u/ml

0.38

388

2356

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1255

9384

1.36

22.74

1.4

1.3

175.25

226.80

u/ml

1.00

1173

8647

Polymyalgia rheumatica

354

2026

1.80

22.69

1.4

1.2

276.93

208.23

u/ml

0.71

325

1836

Endometriosis of rectovaginal septum and vagina

316

1759

1.88

22.69

1.4

1.3

193.97

202.40

u/ml

0.05

293

1610

Other/unspecified enthesopathies, not elsewhere classified

289

1560

1.92

22.65

1.3

224.78

231.18

u/ml

0.05

262

1419

Other symptoms and signs involving the urinary system

351

2011

1.81

22.63

1.2

1.3

153.80

261.48

u/ml

2.78

329

1844

Gonarthrosis, primary, with knee surgery

1652

10165

1.31

22.56

1.3

197.96

249.25

u/ml

1.29

1506

9378

Other condition

548

3528

1.60

22.50

1.4

1.3

324.25

225.26

u/ml

0.68

513

3270

Gout, unspecified

517

3270

1.62

22.50

1.3

442.15

272.33

u/ml

1.42

469

3001

Hyperhidrosis

154

663

2.49

22.47

1.3

121.74

236.66

u/ml

1.87

143

616

Gout, strict definition

457

2807

1.67

22.47

1.3

470.36

281.94

u/ml

1.36

413

2571

Other diseases of the digestive system

893

6321

1.44

22.35

1.3

333.54

260.73

u/ml

0.65

825

5818

Primary gonarthrosis, bilateral

1497

9807

1.33

22.33

1.3

179.48

238.26

u/ml

3.13

1377

9050

Otitis externa, unspecified

452

2791

1.68

22.25

1.4

1.3

324.37

221.75

u/ml

0.43

415

2583

Dislocation, sprain and strain of joints and ligaments of knee

2398

17944

1.25

22.18

1.4

1.3

250.37

246.46

u/ml

0.06

2244

16615

Atypical facial pain

226

1140

2.10

22.09

1.4

1.3

119.03

196.72

u/ml

1.42

209

1048

Hypertrophy of breast in women and men

826

5817

1.46

21.86

1.3

328.55

176.78

u/ml

0.63

767

5384

Sequelae of injuries, of poisoning and of other consequences of external causes

841

5933

1.45

21.79

1.4

1.3

272.62

237.70

u/ml

0.28

794

5506

Extreme obesity with alveolar hypoventilation

171

780

2.34

21.75

1.5

1.2

189.09

197.98

u/ml

0.11

162

717

Disorders of refraction and accommodation

1102

8112

1.38

21.71

1.4

1.3

205.28

236.96

u/ml

0.57

1012

7518

Ulcer of lower limb, not elsewhere classified

400

2398

1.71

21.71

1.4

1.3

440.68

258.93

u/ml

2.40

373

2186

Hallux rigidus

421

2560

1.69

21.68

1.3

1.2

160.59

225.99

u/ml

1.75

394

2344

Weight loss

348

2019

1.79

21.59

1.4

1.3

439.76

226.26

u/ml

0.58

330

1861

Enterocolitis due to Clostridium difficile

329

1878

1.81

21.41

1.5

1.3

308.68

211.52

u/ml

1.01

293

1722

Spondylopathies (FG)

530

3424

1.60

21.40

1.4

1.2

243.85

237.61

u/ml

0.04

507

3172

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

999

6477

1.41

21.36

1.4

1.3

319.90

275.03

u/ml

0.42

909

5996

Trigeminal neuralgia

239

1242

2.02

21.34

1.4

1.3

139.35

201.55

u/ml

0.78

220

1141

Chronic conjunctivitis

148

644

2.49

21.23

1.6

1.2

453.59

200.30

u/ml

1.26

138

591

Lesion of ulnar nerve

471

2966

1.64

21.17

1.3

263.45

248.97

u/ml

0.08

432

2740

Unspecified fall

1728

13400

1.29

21.17

1.3

288.97

257.50

u/ml

0.39

1593

12362

Disorders of oesophagus in diseases classified elsewhere

294

3.24

21.13

1.7

1.2

177.13

268.01

u/ml

0.42

266

Disorders of tooth development and eruption

638

3456

1.53

21.08

1.4

1.3

256.28

250.13

u/ml

0.04

577

3191

Drug-induced osteoporosis

226

3.72

20.99

1.8

1.3

139.60

261.16

u/ml

0.47

205

Chronic ulcer of skin, not elsewhere classified

220

1113

2.06

20.98

1.5

1.3

426.99

241.85

u/ml

0.62

207

1022

Wegener granulomatosis

272

3.40

20.87

1.6

1.3

159.86

238.91

u/ml

0.36

247

Unknown and unspecified causes of morbidity

254

1354

1.95

20.76

1.5

1.2

163.32

218.88

u/ml

0.80

235

1249

Seborrhoeic keratosis

659

4478

1.50

20.75

1.3

144.97

218.16

u/ml

2.75

605

4086

Other metabolic disorders

534

3485

1.58

20.72

1.5

1.3

161.50

185.78

u/ml

0.46

496

3234

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

165

754

2.30

20.70

1.5

1.2

197.16

245.98

u/ml

0.40

157

689

Rheumatoid arthritis, including avohilmo

1266

9606

1.34

20.66

1.3

162.92

220.74

u/ml

2.36

1178

8803

Other and unspecified disorders of white blood cells

166

765

2.31

20.59

1.7

1.3

326.10

233.75

u/ml

0.34

147

703

Other symptoms and signs involving cognitive functions and awareness

1336

9277

1.33

20.55

1.4

1.3

250.61

254.91

u/ml

0.04

1239

8523

Ulcerative colitis

906

6543

1.42

20.53

1.3

209.91

228.40

u/ml

0.19

846

6066

Trigger finger

484

3091

1.61

20.48

1.4

1.3

185.21

211.55

u/ml

0.37

449

2837

Crohn disease

523

3409

1.58

20.43

1.3

162.41

223.35

u/ml

1.38

482

3158

Neuralgia and neuritis, unspecified

202

1014

2.10

19.92

1.4

1.2

161.49

228.67

u/ml

0.73

187

927

GI-bleeding

874

6292

1.41

19.88

1.3

326.36

269.71

u/ml

0.46

808

5797

Myocarditis

184

891

2.16

19.86

1.5

1.2

315.31

278.79

u/ml

0.15

176

819

Protozoal diseases

129

544

2.56

19.82

1.9

1.2

168.99

255.85

u/ml

0.77

114

497

Scabies

211

1082

2.07

19.78

1.6

1.3

330.07

254.37

u/ml

0.25

193

1013

Hyperkinetic disorders

630

4216

1.52

19.75

1.4

1.3

327.89

281.68

u/ml

0.30

583

3918

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

185

910

2.18

19.65

1.4

1.3

285.42

244.54

u/ml

0.27

175

851

Glucagon-like peptide-1 (GLP-1) analogues

1008

7461

1.38

19.62

1.3

239.45

226.24

u/ml

0.24

942

6921

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1008

7461

1.38

19.62

1.3

239.45

226.24

u/ml

0.24

942

6921

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

8.92

19.45

2.0

1.2

132.41

613.97

u/ml

0.46

Malignant neoplasm of breast, HER2-negative

1008

8854

0.73

19.30

1.2

1.3

185.00

187.52

u/ml

0.03

909

8225

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

166

790

2.26

19.25

1.3

1.2

222.47

213.78

u/ml

0.06

159

736

Biological medication for rheuma

701

4907

1.47

19.24

1.4

1.3

151.37

227.33

u/ml

2.26

658

4553

Spondyloarthritis

616

4197

1.50

19.21

1.4

1.3

235.06

219.93

u/ml

0.11

590

3874

Necrosis of pulp, including avohilmo

2240

18315

1.24

19.21

1.3

218.88

242.27

u/ml

0.66

2065

17032

Other abnormal uterine and vaginal bleeding

822

4196

1.43

19.19

1.3

189.49

199.08

u/ml

0.07

749

3854

Ehlers-Danlos syndrome

247

3.54

19.16

1.4

1.2

221.96

230.60

u/ml

0.02

227

Hypertrophy of breast

750

5327

1.45

19.10

1.3

334.45

168.92

u/ml

0.62

698

4931

Diplopia

435

2760

1.62

19.04

1.4

1.3

309.66

212.73

u/ml

0.67

404

2541

Ehlers-Danlos syndrome

324

3.15

18.99

1.4

1.2

211.01

233.28

u/ml

0.08

300

Psoriatic and enteropathic arthropathies

417

2627

1.64

18.84

1.3

195.49

210.75

u/ml

0.14

389

2440

Pleural effusion

394

2441

1.65

18.81

1.5

1.3

254.51

265.36

u/ml

0.08

363

2225

Renal tubulo-interstitial diseases

3169

19939

1.19

18.77

1.4

1.3

281.04

234.48

u/ml

1.20

2921

18446

Hypokalaemia

380

2340

1.67

18.76

1.5

1.3

270.44

222.81

u/ml

0.23

358

2155

Ulcerative colitis, NAS

532

3546

1.54

18.72

1.3

231.77

221.84

u/ml

0.06

493

3282

Abnormal weight loss

305

1778

1.78

18.67

1.4

1.3

494.00

226.77

u/ml

0.66

288

1637

Injury of muscle and tendon at shoulder and upper arm level

1037

7760

1.36

18.64

1.3

217.72

271.34

u/ml

0.71

953

7177

Neuromuscular dysfunction of bladder

304

1771

1.78

18.61

1.5

1.3

264.76

241.49

u/ml

0.12

273

1635

Psoriatic arthropathies

342

2057

1.72

18.57

1.3

1.2

204.26

242.57

u/ml

0.34

320

1902

Hypopituitarism

290

1675

1.81

18.51

1.5

1.3

266.76

252.90

u/ml

0.04

269

1557

Purpura and other haemorrhagic conditions

455

2937

1.59

18.51

1.4

1.3

322.67

219.10

u/ml

1.26

402

2708

Malignant neoplasm of breast

1037

8985

0.74

18.46

1.2

1.3

186.67

187.76

u/ml

0.01

938

8345

Anomalies of dental arch relationship, including avohilmo

870

5732

1.40

18.39

1.4

1.3

189.62

240.63

u/ml

1.19

818

5290

Other problems related to primary support group, including family circumstances

554

3646

1.53

18.36

1.4

1.3

198.67

239.15

u/ml

0.61

504

3393

Other female pelvic inflammatory diseases

614

4233

1.49

18.32

1.4

1.3

170.24

179.83

u/ml

0.13

570

3888

Disorders of breast

1974

14573

1.25

18.26

1.3

234.62

181.79

u/ml

0.47

1830

13473

Nonalcoholic fatty liver disease

376

2335

1.67

18.22

1.4

1.3

272.84

209.16

u/ml

0.61

357

2161

Fracture of rib(s), sternum and thoracic spine

860

6273

1.39

18.22

1.3

287.67

264.90

u/ml

0.21

799

5796

Diseases of male genital organs

1500

5883

1.30

18.21

1.3

372.22

376.72

u/ml

0.03

1394

5486

Viral warts

389

2436

1.66

18.19

1.6

1.3

600.96

203.05

u/ml

0.89

364

2252

Other congenital malformations of skin

195

1005

2.07

18.19

1.5

1.3

149.86

223.69

u/ml

1.16

177

933

Other hearing loss

709

4892

1.44

18.16

1.3

165.30

252.44

u/ml

4.02

644

4461

Inflammatory diseases of prostate (prostatitis)

328

1958

1.72

18.15

1.3

161.13

343.54

u/ml

6.71

301

1806

Paralytic ileus and intestinal obstruction

695

4886

1.45

18.14

1.4

1.3

216.95

250.93

u/ml

0.35

645

4481

Female genital prolapse

1052

4424

1.37

18.12

1.4

1.3

150.59

193.39

u/ml

1.23

980

4079

Abnormal blood-pressure reading, without diagnosis

152

711

2.23

17.98

1.5

1.2

654.74

237.27

u/ml

0.73

132

660

Pacemaker

756

5176

1.42

17.90

1.3

179.15

267.44

u/ml

3.83

694

4713

Problems related to lifestyle

402

2545

1.63

17.86

1.2

337.92

194.94

u/ml

2.00

371

2360

Convulsions, not elsewhere classified

782

5564

1.41

17.83

1.4

1.2

326.57

280.15

u/ml

0.44

709

5173

Cluster headache, strict, including avohilmo

229

1251

1.93

17.82

1.3

162.36

227.07

u/ml

0.82

215

1167

Gastric ulcer

446

2881

1.58

17.79

1.3

288.62

274.37

u/ml

0.06

418

2636

Chondropathies

578

3960

1.50

17.78

1.4

1.3

370.45

218.74

u/ml

0.43

551

3678

Cerebrovascular diseases (FINNGEN)

1052

5583

1.35

17.73

1.3

244.53

241.05

u/ml

0.03

982

5204

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

195

1010

2.03

17.69

1.3

1.2

186.49

222.54

u/ml

0.32

183

931

Cluster headache, wide,, including avohilmo

237

1311

1.91

17.69

1.3

158.31

223.68

u/ml

0.88

223

1220

Malignant neoplasm of breast, including Hilmo

1078

9164

0.75

17.66

1.2

1.3

185.56

187.71

u/ml

0.03

977

8511

Malignant neoplasm of breast, HER2-negative, including Hilmo

1078

9164

0.75

17.65

1.2

1.3

185.56

187.71

u/ml

0.03

977

8511

Alopecia areata

137

627

2.36

17.61

1.5

1.3

637.75

215.02

u/ml

1.71

130

586

Vulvovaginal ulceration/inflammation in other diseases

295

1745

1.78

17.53

1.4

1.3

208.88

200.64

u/ml

0.05

274

1621

Other and unspecified visual disturbances

364

2262

1.67

17.53

1.5

1.3

255.23

196.96

u/ml

0.32

336

2086

Other neurological diseases

2285

14834

1.22

17.47

1.3

207.37

250.49

u/ml

1.24

2078

13722

Colonic or urogenital fistula

889

6576

1.38

17.40

1.3

160.69

246.40

u/ml

3.23

829

6064

N06DA Anticholinesterases

324

4163

0.61

17.35

1.2

1.3

236.22

257.82

u/ml

0.23

279

3768

Use of anticholinesterases

324

4163

0.61

17.35

1.2

1.3

236.22

257.82

u/ml

0.23

279

3768

Mature T/NK-cell lymphomas, hilmo

206

3.49

17.27

1.7

1.2

2249.28

221.87

u/ml

0.69

187

Injuries to the head

4326

23133

1.16

17.20

1.3

255.50

248.49

u/ml

0.13

3997

21430

Hordeolum and other deep inflammation of eyelid

238

1328

1.88

17.16

1.4

1.3

271.88

212.49

u/ml

0.33

210

1222

Blepharochalasis

838

6154

1.39

17.11

1.3

133.02

216.99

u/ml

5.33

751

5605

Spontaneous rupture of synovium and tendon

255

1448

1.82

17.06

1.5

1.2

172.82

215.83

u/ml

0.43

235

1325

Other congenital malformations

547

3748

1.51

16.95

1.5

1.3

254.81

211.73

u/ml

0.29

505

3480

Procreative management

1356

8877

1.30

16.95

1.4

1.3

203.10

260.78

u/ml

1.63

1250

8238

Hyperparathyroidism

511

3402

1.52

16.88

1.3

181.75

203.29

u/ml

0.25

478

3111

Pneumothorax

214

1156

1.92

16.88

1.5

1.3

267.79

229.17

u/ml

0.30

199

1057

Pure hypercholesterolaemia

2321

12544

1.22

16.86

1.3

227.04

251.97

u/ml

0.64

2145

11609

Pneumonia derived septicemia

128

577

2.34

16.75

1.6

1.2

146.99

235.09

u/ml

0.92

115

529

Iridocyclitis

758

5507

1.40

16.67

1.4

1.3

259.09

195.93

u/ml

0.62

703

5082

Infections with a predominantly sexual mode of transmission

1701

12821

1.26

16.63

1.3

335.83

232.93

u/ml

0.89

1546

11895

Tobacco use

217

1191

1.91

16.58

1.3

355.13

229.04

u/ml

1.34

199

1099

Personality disorders

1098

8448

1.33

16.51

1.3

278.34

218.17

u/ml

0.28

995

7832

Other disorders of bladder

342

2119

1.66

16.51

1.3

220.53

264.69

u/ml

0.35

316

1941

Benign neoplasm: Stomach

311

1886

1.71

16.49

1.6

1.3

147.30

200.60

u/ml

1.40

293

1719

Superficial injury of ankle and foot

502

3401

1.52

16.48

1.4

1.3

211.57

230.83

u/ml

0.22

480

3153

Pediculosis, acariasis and other infestations

241

1367

1.84

16.47

1.5

1.3

303.16

245.34

u/ml

0.21

221

1269

Streptococcal septicaemia

263

1523

1.78

16.44

1.4

1.3

187.38

225.25

u/ml

0.55

236

1408

Crohn's disease NAS

266

1553

1.79

16.43

1.4

1.3

176.77

208.59

u/ml

0.37

248

1444

Thyroiditis, ILD-related definition

457

3039

1.55

16.42

1.4

1.3

123.75

188.76

u/ml

2.39

421

2809

Malignant neoplasm of digestive organs

566

6403

0.69

16.39

1.2

1.3

209.08

244.49

u/ml

0.65

508

5918

Postmenopausal atrophic vaginitis

882

3580

1.39

16.34

1.3

166.04

195.19

u/ml

0.54

812

3301

Reactive arthropathies

294

1763

1.72

16.23

1.4

1.2

230.69

238.47

u/ml

0.05

276

1629

SLE (Finngen)

151

740

2.17

16.15

1.3

1.2

136.33

157.01

u/ml

0.23

136

676

Acute nasopharyngitis (common cold)

397

2548

1.59

16.07

1.4

1.3

483.10

265.57

u/ml

1.14

371

2383

Other specified/unspecified soft tissue disorders

164

825

2.07

16.06

1.3

1.2

125.02

203.78

u/ml

1.29

149

753

ILD and respiratory illness in diseases classified elsewhere

5.24

16.02

1.5

1.3

262.24

186.07

u/ml

0.29

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

965

7316

1.34

16.01

1.4

1.3

218.45

257.70

u/ml

0.72

901

6777

Other disorders starting during childhood or adolecense, excluding more controls

251

1392

1.82

15.99

1.5

1.3

389.86

278.15

u/ml

0.52

228

1280

Scoliosis

323

1996

1.67

15.95

1.3

191.10

205.76

u/ml

0.10

294

1835

Disorders of adult personality and behaviour

1162

9049

1.31

15.95

1.3

275.14

218.29

u/ml

0.28

1057

8394

Crohn's disease of small intestine

285

1711

1.74

15.91

1.3

148.21

215.82

u/ml

1.19

269

1585

Early lumbar disc prolapse, operated

402

2618

1.58

15.88

1.3

207.76

297.15

u/ml

1.07

382

2438

Congenital malformations of the musculoskeletal system, not elsewhere classified

397

2.70

15.88

1.4

1.3

197.05

254.74

u/ml

0.27

369

Nontoxic multinodular goitre

594

4176

1.45

15.82

1.3

116.38

203.95

u/ml

4.20

542

3802

Other CVD

487

3292

1.51

15.77

1.4

1.3

273.73

240.68

u/ml

0.19

449

2993

Congenital malformations of the musculoskeletal system, not elsewhere classified

111

491

2.50

15.77

1.4

1.3

189.80

256.05

u/ml

0.38

103

457

Perforation of tympanic membrane

342

2150

1.64

15.73

1.5

1.3

292.19

210.95

u/ml

0.54

318

1974

Appendectomy

2499

20165

1.20

15.70

1.3

193.42

239.88

u/ml

1.72

2316

18712

Benign neoplasm: Transverse colon

310

1903

1.68

15.64

1.4

1.3

187.85

229.41

u/ml

0.52

286

1744

Presbycusis

276

1620

1.72

15.60

1.3

1.2

161.25

262.41

u/ml

2.99

244

1462

Unspecific neurodegenerative disorder

474

4766

0.67

15.57

1.2

1.3

259.75

255.94

u/ml

0.04

418

4318

Drug-induced cataract

110

484

2.46

15.54

1.5

1.2

282.10

219.94

u/ml

0.26

102

447

Acne

474

3212

1.52

15.52

1.3

282.85

255.39

u/ml

0.21

444

2971

Special screening examination for other diseases and disorders

324

2009

1.65

15.50

1.4

1.2

299.01

251.83

u/ml

0.44

301

1825

Diseases of appendix

2793

21459

1.18

15.43

1.3

246.89

243.31

u/ml

0.04

2601

19905

Disorders of continuity of bone

364

2339

1.61

15.32

1.5

1.3

179.90

210.75

u/ml

0.52

331

2160

Follicular cysts of skin and subcutaneous tissue

595

4212

1.44

15.31

1.3

215.32

230.32

u/ml

0.23

550

3898

Adjustment and management of implanted device

446

2981

1.52

15.29

1.3

184.32

273.08

u/ml

2.89

413

2720

Glomerular diseases

556

3891

1.46

15.23

1.3

359.40

256.69

u/ml

0.47

504

3598

Ulcer of oesophagus

187

1000

1.93

15.22

1.4

1.3

254.82

249.96

u/ml

0.02

179

913

Other noninflammatory disorders of vulva and perineum

365

2352

1.60

15.17

1.3

436.14

210.75

u/ml

0.38

336

2159

Hypertensive heart and/or renal disease

625

3302

1.43

15.16

1.3

235.83

244.37

u/ml

0.11

580

3003

Benign neoplasm: Ascending colon

387

2521

1.57

15.15

1.4

1.3

193.39

211.94

u/ml

0.25

357

2313

Intestinal malabsorption

185

994

1.96

15.15

1.5

1.3

352.16

212.56

u/ml

0.39

170

921

Other diseases of stomach and duodenum

197

1075

1.90

15.13

1.5

1.2

463.55

204.77

u/ml

0.52

186

985

Injuries to the abdomen, lower back, lumbar spine and pelvis

1253

9790

1.28

15.10

1.4

1.3

313.01

244.14

u/ml

0.38

1158

9017

Schizophrenia

251

4161

0.59

15.08

1.2

1.3

798.11

241.41

u/ml

0.66

211

3887

Varicose veins

1967

12271

1.22

15.07

1.3

199.13

238.94

u/ml

0.86

1808

11340

Appendicitis, broad definition

2770

21394

1.18

15.01

1.3

246.81

243.67

u/ml

0.04

2580

19849

Impetigo

217

1233

1.86

14.97

1.7

1.3

1817.76

224.66

u/ml

4.28

208

1151

Female infertility

1261

6023

1.29

14.89

1.3

147.80

195.87

u/ml

1.79

1167

5576

Sequelae of other external causes

205

1142

1.87

14.87

1.6

1.3

299.91

212.06

u/ml

0.77

192

1052

Oesophagitis

170

890

1.98

14.86

1.6

1.2

328.37

219.17

u/ml

0.64

159

820

Other and unspecified epidermal thickening

113

512

2.36

14.80

1.4

1.2

254.00

266.47

u/ml

0.05

105

467

Other otitis externa (chronic)

243

1425

1.78

14.79

1.5

1.3

248.96

216.00

u/ml

0.18

225

1319

Olecranon bursitis

181

969

1.93

14.74

1.4

1.2

415.93

249.49

u/ml

1.01

168

882

Other benign neoplasms of skin

1149

9013

1.29

14.74

1.3

209.60

220.27

u/ml

0.15

1058

8267

Endometriosis ASRM stages 1,2

753

5596

1.38

14.69

1.3

127.38

179.89

u/ml

1.16

687

5186

Hypotension

399

2628

1.55

14.68

1.4

1.3

303.26

244.04

u/ml

0.30

366

2382

Postprocedural disorders of nervous system

327

2077

1.64

14.68

1.3

224.74

186.28

u/ml

0.21

301

1940

Explicit bacterial Sepsis

313

1959

1.64

14.55

1.4

1.3

203.52

241.85

u/ml

0.56

279

1804

Superficial injury of hip and thigh

436

2935

1.52

14.55

1.3

192.52

218.53

u/ml

0.49

405

2688

Fitting and adjustment of other devices

940

6481

1.33

14.47

1.3

179.11

239.86

u/ml

2.38

872

5924

Corticotropin deficiency

157

3.70

14.45

1.9

1.3

140.37

154.55

u/ml

0.11

146

Secondary hypertension

245

1425

1.75

14.44

1.2

1.3

224.46

290.24

u/ml

0.66

230

1310

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

345

2194

1.61

14.42

1.4

1.3

265.35

235.39

u/ml

0.20

323

2047

Female infertility, cervical, vaginal, other or unspecified origin

1149

5844

1.30

14.41

1.3

139.60

193.10

u/ml

2.34

1064

5421

Panniculitis affecting regions of neck and back

140

695

2.11

14.38

1.5

1.3

177.42

175.97

u/ml

0.01

132

645

Acute appendicitis, no complications

2118

17691

1.21

14.37

1.3

223.57

237.40

u/ml

0.25

1968

16429

Convalescence

205

1156

1.85

14.33

1.4

1.3

256.53

189.98

u/ml

0.37

188

1067

Fracture of foot, except ankle

890

6789

1.34

14.29

1.4

1.3

216.10

220.84

u/ml

0.06

842

6278

Tumor necrosis factor alpha inhibitors

619

4476

1.42

14.29

1.3

142.25

221.72

u/ml

2.52

578

4162

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

319

4887

0.63

14.25

1.3

321.91

234.58

u/ml

0.49

290

4499

Other specified/unspecified inflammatory spondylopathies

194

1079

1.88

14.21

1.3

204.08

204.12

u/ml

0.00

185

997

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1573

8127

1.25

14.16

1.4

1.3

236.95

192.44

u/ml

0.48

1473

7544

IBD patients in KELA-register

844

6400

1.34

14.15

1.3

227.10

245.75

u/ml

0.16

785

5937

Acute gastritis

223

1291

1.78

14.04

1.4

1.3

274.46

229.30

u/ml

0.29

201

1186

Stenosis and insufficiency of lacrimal passages

298

1864

1.65

14.02

1.4

1.3

181.87

196.03

u/ml

0.14

276

1708

Superficial injury of wrist and hand

772

5791

1.36

14.00

1.3

210.19

236.47

u/ml

0.30

709

5369

Abnormal serum enzyme levels

760

5528

1.36

13.96

1.3

337.32

297.98

u/ml

0.21

711

5114

Hypertensive Heart Disease

548

3019

1.44

13.93

1.3

216.11

247.39

u/ml

0.52

507

2744

Right bundle-branch block

108

490

2.30

13.86

1.5

1.3

425.51

253.00

u/ml

0.40

100

454

Ankylosing spondylitis

286

1776

1.66

13.84

1.4

1.3

230.00

249.36

u/ml

0.07

272

1646

Pyogenic arthritis

198

1112

1.84

13.84

1.2

354.53

243.56

u/ml

0.62

185

1013

False labour

1457

7353

1.26

13.75

1.3

167.72

205.61

u/ml

0.67

1348

6834

Faecal incontinence

268

1640

1.68

13.73

1.4

1.2

134.62

205.27

u/ml

1.96

253

1498

Complications of internal orthopaedic prosthetic devices, implants and grafts

591

4255

1.41

13.72

1.3

208.62

230.49

u/ml

0.34

537

3860

Unstable angina pectoris

853

5097

1.34

13.67

1.4

1.3

233.26

295.32

u/ml

0.68

780

4662

Other disorders of conjunctiva

407

2743

1.52

13.62

1.3

225.58

191.71

u/ml

0.31

378

2510

Open wound of wrist and hand

1549

12401

1.24

13.51

1.3

319.45

265.93

u/ml

0.60

1437

11494

Seropositive rheumatoid arthritis, wide

815

6189

1.34

13.48

1.3

155.67

216.05

u/ml

2.54

755

5662

Fall on same level involving ice and snow

1965

16476

1.21

13.47

1.4

1.3

222.16

248.98

u/ml

0.59

1825

15216

STROKE

1777

9982

1.22

13.46

1.3

228.01

254.93

u/ml

0.47

1632

9267

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

5.58

13.45

1.4

1.3

77.10

172.88

u/ml

1.85

Other pleural conditions

248

1493

1.70

13.45

1.4

1.3

193.61

233.44

u/ml

0.37

236

1368

Degenerative diseases of the nervous system

375

4110

0.66

13.42

1.2

1.3

278.09

255.30

u/ml

0.25

336

3722

Deep endometriosis

375

2505

1.55

13.37

1.4

1.3

178.80

163.16

u/ml

0.11

346

2313

Other peripheral vascular diseases

285

1788

1.65

13.35

1.2

1.3

181.74

205.93

u/ml

0.28

266

1650

Acute appendicitis

2601

20864

1.18

13.35

1.3

228.36

240.52

u/ml

0.23

2421

19367

Other maternal disorders predominantly related to pregnancy

2459

13137

1.19

13.31

1.3

163.79

201.31

u/ml

1.33

2256

12176

Injuries to the shoulder and upper arm

2904

20217

1.17

13.30

1.3

255.56

259.62

u/ml

0.06

2696

18701

Other erythematous conditions

132

662

2.10

13.28

1.3

1.2

384.74

217.31

u/ml

0.61

118

606

Car occupant injured in other and unspecified transport accidents

699

5213

1.37

13.22

1.4

1.3

191.94

224.08

u/ml

0.66

656

4830

Nontoxic goitre/thyroid nodule

917

7097

1.31

13.21

1.3

110.19

189.40

u/ml

6.78

835

6488

Acute and subacute iridocyclitis

621

4547

1.39

13.16

1.4

1.3

245.82

195.05

u/ml

0.40

581

4207

Statin medication

2712

13076

1.18

13.11

1.3

221.94

233.87

u/ml

0.12

2525

12170

Leisure time condition

606

4424

1.40

13.11

1.4

1.3

285.91

233.60

u/ml

0.77

563

4081

AV-block

404

2389

1.50

13.01

1.2

1.3

222.06

294.88

u/ml

1.09

365

2183

Hyperplasia of prostate

827

3539

1.34

13.00

1.4

1.3

267.53

344.16

u/ml

1.25

754

3294

Persistent mood disorders

650

4803

1.38

12.99

1.3

269.20

196.96

u/ml

0.90

589

4457

Arthropathies in other diseases classified elsewhere

127

632

2.11

12.99

1.4

1.2

266.13

250.12

u/ml

0.05

116

573

Polyarthritis, unspecified

129

646

2.09

12.97

1.3

1.2

163.65

221.52

u/ml

0.53

121

586

Examination and encounter for administrative purposes

128

636

2.08

12.97

1.4

1.2

173.90

267.98

u/ml

1.01

122

572

Acute lymphadenitis

242

1472

1.71

12.97

1.6

1.3

401.29

219.35

u/ml

1.12

219

1354

Short Achilles tendon (acquired)

114

547

2.21

12.95

1.5

1.2

159.55

217.44

u/ml

0.44

105

501

Bruxism

103

479

2.34

12.94

1.7

1.2

194.60

201.24

u/ml

0.03

447

Anterior Iridocyclitis

657

4867

1.38

12.94

1.4

1.3

257.86

213.82

u/ml

0.34

612

4504

Other obstetric conditions, not elsewhere classified

1593

8337

1.24

12.91

1.4

1.3

235.84

190.28

u/ml

0.51

1490

7740

Other deformities of toe(s)

125

621

2.11

12.86

1.3

1.2

176.21

203.16

u/ml

0.16

114

560

Other strabismus

832

6366

1.33

12.84

1.4

1.3

237.24

224.10

u/ml

0.14

771

5903

Other coagulation defects

279

1761

1.64

12.82

1.4

1.3

112.87

212.48

u/ml

3.42

263

1634

Other and unspecified disorders of skin and subcutaneous tissue

215

1269

1.76

12.80

1.4

1.2

234.39

209.35

u/ml

0.16

186

1165

Substance use, excluding alcohol

710

5332

1.36

12.80

1.4

1.3

350.95

251.19

u/ml

1.23

665

4960

Type 2 diabetes, wide definition

2556

14008

1.18

12.79

1.3

273.46

236.07

u/ml

0.84

2363

12973

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2320

15665

1.19

12.77

1.3

200.52

204.19

u/ml

0.06

2152

14519

Idiopathic gout

235

1417

1.70

12.75

1.4

1.3

412.68

252.25

u/ml

1.42

219

1298

Benign neoplasm of mouth and pharynx

341

2251

1.56

12.72

1.4

1.3

225.65

216.12

u/ml

0.07

319

2078

Monoamine oxidase A inhibitors

360

2403

1.53

12.68

1.3

184.30

234.55

u/ml

0.70

324

2229

Barrett oesophagus

146

769

1.97

12.63

1.4

1.3

342.44

228.80

u/ml

0.47

131

708

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

791

6040

1.33

12.62

1.3

146.34

215.70

u/ml

3.47

732

5528

Atrophic disorders of skin

494

3511

1.44

12.61

1.4

1.3

172.09

188.79

u/ml

0.30

454

3242

Cramp and spasm

184

1048

1.84

12.57

1.4

1.3

146.71

213.96

u/ml

1.30

172

967

Specific personality disorders

934

7304

1.30

12.56

1.3

304.92

208.53

u/ml

0.41

843

6769

Dissociative [conversion] disorders

176

991

1.87

12.55

1.4

1.3

161.21

202.69

u/ml

0.46

163

927

Erythema intertrigo

348

2.49

12.47

1.4

1.2

191.67

170.54

u/ml

0.15

315

Other peripheral vertigo

286

1825

1.61

12.46

1.3

93.24

196.97

u/ml

5.74

267

1674

Spinal instabilities

110

529

2.20

12.42

1.2

267.27

188.07

u/ml

0.30

101

488

Other noninfective disorders of lymphatic vessels and lymph nodes

141

742

2.00

12.40

1.4

1.3

205.39

214.58

u/ml

0.07

130

678

Giant cell arteritis

123

615

2.09

12.39

1.3

1.2

195.10

206.32

u/ml

0.06

114

553

Ventral hernia

698

5249

1.35

12.38

1.3

271.81

239.84

u/ml

0.21

654

4823

Oligomenorrhoea

166

923

1.89

12.37

1.3

1.2

743.71

216.95

u/ml

0.42

154

852

Anosmia

356

2.44

12.36

1.4

1.2

331.85

242.24

u/ml

0.27

321

Other/unspecified seropositive rheumatoid arthritis

797

6114

1.32

12.30

1.3

150.70

216.11

u/ml

3.09

737

5595

Non-Hodgkin lymphoma, all, including Hilmo

364

2452

1.52

12.25

1.5

1.3

740.95

228.98

u/ml

0.99

315

2260

Erosion of teeth , including avohilmo

948

7452

1.29

12.24

1.4

1.3

216.87

232.13

u/ml

0.19

890

6893

Alzheimer disease, including avohilmo

384

3946

0.68

12.23

1.2

1.3

248.83

251.34

u/ml

0.03

336

3569

Inflammatory diseases of the central nervous system

293

1892

1.60

12.18

1.4

1.3

234.61

214.79

u/ml

0.13

275

1745

Pericarditis

116

572

2.12

12.15

1.5

1.3

516.46

270.37

u/ml

0.64

111

530

Inflammatory bowel disease, strict (require KELA)

844

6542

1.31

12.14

1.3

227.10

233.03

u/ml

0.05

785

6063

Other bullous disorders

110

535

2.18

12.13

1.6

1.3

660.36

242.43

u/ml

1.76

105

487

Disturbances of smell and taste

156

854

1.91

12.13

1.3

242.09

202.05

u/ml

0.20

144

780

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

294

1901

1.59

12.12

1.4

1.3

197.33

265.30

u/ml

0.82

272

1762

Other superficial mycoses

457

2.30

12.11

1.5

1.2

170.89

170.35

u/ml

0.00

420

Volume depletion

244

1507

1.66

12.03

1.3

375.04

234.51

u/ml

0.83

225

1387

Heterophoria

320

2116

1.56

12.03

1.4

1.3

292.50

211.40

u/ml

0.54

296

1950

Congenital malformations and deformations of the musculoskeletal system

476

3379

1.44

12.02

1.4

1.3

399.78

246.37

u/ml

0.57

439

3140

Left bundle-branch block

197

1152

1.76

12.02

1.3

1.2

264.74

240.20

u/ml

0.09

184

1051

Congenital malformations and deformations of the musculoskeletal system

398

2739

1.49

12.01

1.5

1.3

314.51

247.09

u/ml

0.35

366

2548

Misadventures to patients during surgical and medical care

450

3173

1.45

12.00

1.4

1.3

243.79

202.65

u/ml

0.45

422

2922

Chondrocostal junction syndrome [Tietze]

151

824

1.93

11.93

1.5

1.2

172.82

203.01

u/ml

0.27

145

759

Glomerular disorders in diseases classified elsewhere

343

2299

1.53

11.90

1.2

1.3

411.04

234.67

u/ml

0.51

304

2114

L04AC Interleukin inhibitors

238

1476

1.68

11.88

1.5

1.3

225.02

217.20

u/ml

0.04

225

1371

Other and unspecified erythematous conditions

119

600

2.09

11.87

1.3

1.2

410.13

227.02

u/ml

0.60

106

547

Other disorders of kidney and ureter

376

2569

1.50

11.85

1.3

212.69

218.32

u/ml

0.06

351

2346

Malignant neoplasm of breast, HER-positive

728

7405

0.75

11.81

1.2

1.3

211.91

187.54

u/ml

0.30

657

6864

Postprocedural endocrine and metabolic disorders, not elsewhere classified

454

3220

1.45

11.80

1.5

1.3

158.91

190.18

u/ml

0.59

422

2995

Systemic lupus erythematosus

151

828

1.92

11.80

1.3

1.2

136.33

181.29

u/ml

0.48

136

759

Speech and linguistic disorders, excluding more controls

346

2191

1.53

11.80

1.4

1.3

440.41

279.84

u/ml

0.44

317

2031

Unspecified kidney failure

238

1472

1.65

11.67

1.3

321.57

247.12

u/ml

0.25

220

1345

conjunctival haemorrhage

219

1332

1.69

11.62

1.4

1.3

174.72

192.08

u/ml

0.13

207

1224

Other disorders of pigmentation

160

895

1.87

11.62

1.3

1.2

188.65

222.34

u/ml

0.24

150

814

Reactive arthropathies, FINNGEN

246

1543

1.65

11.60

1.4

1.3

224.22

226.96

u/ml

0.01

231

1428

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

311

2059

1.55

11.52

1.5

1.3

340.70

217.10

u/ml

0.70

289

1899

Cytomegalovirus infection, IBD co-morbidity

447

2.27

11.49

1.6

1.3

482.50

236.37

u/ml

0.49

413

Haemorrhage in early pregnancy

1158

9138

1.25

11.49

1.3

148.73

193.28

u/ml

1.38

1069

8474

Contraceptive management

1650

9664

1.21

11.48

1.3

173.50

256.56

u/ml

4.93

1556

8985

Additional codes for the location of defect, injury or illness

206

1241

1.72

11.48

1.3

293.32

220.44

u/ml

0.40

191

1155

Bacterial, viral and other infectious agents

325

2176

1.54

11.46

1.5

1.3

230.46

253.51

u/ml

0.21

308

2021

Endometriosis of ovary

620

4530

1.36

11.45

1.3

137.47

190.94

u/ml

1.40

571

4187

Dementia

562

5230

0.73

11.39

1.3

242.70

249.35

u/ml

0.08

499

4751

Other or unspecified ileus, impaction or obstruction

456

3247

1.43

11.33

1.4

1.3

173.37

267.17

u/ml

2.20

425

2979

Malignant neoplasm of breast, ER-positive, including Hilmo

755

7518

0.76

11.32

1.2

1.3

214.24

186.62

u/ml

0.35

683

6969

Excessive earwax

1646

13470

1.20

11.28

1.3

288.27

252.94

u/ml

0.37

1535

12412

Other encephalitis

110

550

2.11

11.28

1.5

1.3

121.32

232.73

u/ml

1.47

102

505

Gluteal tendinitis

140

758

1.93

11.28

1.4

1.3

204.65

166.92

u/ml

0.24

132

703

Postmenopausal bleeding

819

3362

1.32

11.27

1.3

162.59

193.02

u/ml

0.65

726

3107

Fracture at wrist and hand level

1155

9347

1.25

11.27

1.3

418.32

269.80

u/ml

1.22

1068

8659

Dialysis, with operation codes

371

2555

1.49

11.26

1.3

335.05

246.96

u/ml

0.48

346

2357

Familial hypercholesterolemia

372

2558

1.48

11.25

1.2

1.3

195.55

259.05

u/ml

1.02

346

2334

Chronic suppurative otitis media, including avohilmo

273

1768

1.59

11.24

1.5

1.3

423.32

231.55

u/ml

0.87

256

1633

Glaucoma suspect

987

7867

1.27

11.21

1.3

178.64

231.68

u/ml

1.72

908

7200

Coxarthrosis, primary

1587

11217

1.21

11.18

1.3

293.87

238.01

u/ml

0.63

1441

10352

Psychotic depression

208

1263

1.70

11.14

1.3

323.48

232.42

u/ml

0.37

184

1169

Encephalitis

117

602

2.05

11.07

1.5

1.3

118.24

234.35

u/ml

1.76

106

556

Acute tubulo-interstitial nephritis

2098

15500

1.18

11.06

1.4

1.3

233.11

228.87

u/ml

0.06

1933

14281

Adalimumab

375

2606

1.48

11.03

1.3

108.67

224.07

u/ml

5.97

355

2424

Effects of foreign body entering through natural orifice

794

6187

1.30

10.97

1.3

233.21

284.73

u/ml

0.74

745

5755

SLE, ICD10

145

805

1.90

10.94

1.3

1.2

142.45

185.63

u/ml

0.43

130

735

SLE, strict definition

145

805

1.90

10.94

1.3

1.2

142.45

185.63

u/ml

0.43

130

735

Phlebitis and thrombophlebitis (not including DVT)

683

5218

1.33

10.94

1.4

1.3

181.77

226.55

u/ml

1.14

629

4815

Sacroiliitis, not elsewhere classified

191

1145

1.73

10.88

1.3

210.91

212.60

u/ml

0.01

185

1064

Diseases of arteries, arterioles and capillaries

1814

11330

1.19

10.86

1.3

281.44

245.94

u/ml

0.68

1671

10440

Recurrent dislocation and subluxation of joint

258

1663

1.60

10.86

1.4

1.3

182.09

260.59

u/ml

1.02

236

1543

Other disorders of binocular vision

298

2.56

10.84

1.5

1.3

118.09

173.55

u/ml

0.84

276

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1504

10030

1.21

10.83

1.3

364.49

227.50

u/ml

2.54

1383

9247

Benign neoplasm: Caecum

285

1876

1.56

10.82

1.4

1.3

161.01

201.44

u/ml

0.86

258

1712

Cytomegaloviral disease

478

2.18

10.82

1.6

1.3

467.10

238.30

u/ml

0.46

442

Benign neoplasm: Rectum

478

3467

1.40

10.81

1.3

162.02

234.40

u/ml

2.65

430

3176

Pneumococcal septicemia

123

649

1.99

10.78

1.6

1.3

151.67

258.77

u/ml

1.27

110

592

Strabismus

941

7486

1.27

10.78

1.3

223.83

240.30

u/ml

0.19

872

6932

Presence of cardiac and vascular implants and grafts

1052

6273

1.26

10.76

1.2

1.3

198.08

289.76

u/ml

3.89

967

5781

Contusion of other and unspecified parts of foot

212

1312

1.68

10.73

1.3

233.42

229.34

u/ml

0.03

201

1217

Superficial injury of shoulder and upper arm

373

2599

1.47

10.70

1.3

236.10

228.27

u/ml

0.07

356

2405

Diseases of the myoneural junction and muscle

346

2375

1.49

10.69

1.4

1.3

269.50

229.20

u/ml

0.37

318

2177

Acne vulgaris

357

2475

1.49

10.67

1.3

263.30

256.69

u/ml

0.05

333

2284

Sequelae of injuries of upper limb

330

2251

1.51

10.64

1.4

1.3

158.56

209.26

u/ml

1.14

308

2087

Other noninflammatory disorders of vagina

280

1847

1.56

10.63

1.2

1.3

120.93

210.63

u/ml

3.02

254

1693

Other and unspecified injuries of ankle and foot

179

1064

1.76

10.61

1.3

168.18

213.35

u/ml

0.72

174

980

Postmenopausal osteoporosis with pathological fracture

167

969

1.78

10.59

1.5

1.2

211.89

168.28

u/ml

0.31

150

875

Other infective otitis externa

208

1283

1.68

10.59

1.4

1.3

524.98

201.90

u/ml

0.73

195

1191

Major coronary heart disease event excluding revascularizations

1532

8515

1.21

10.54

1.4

1.3

287.51

278.77

u/ml

0.09

1401

7841

Emotionally unstable personality disorder

525

3894

1.38

10.54

1.3

365.90

206.68

u/ml

0.38

474

3619

Nephropathy related operations

359

2491

1.47

10.53

1.3

265.12

232.27

u/ml

0.29

334

2290

Other (seronegative) rheumatoid arthritis, wide

553

4123

1.36

10.53

1.3

159.55

197.85

u/ml

1.20

514

3777

Chalazion

374

2617

1.46

10.51

1.3

448.24

219.48

u/ml

0.75

351

2406

Any dementia

473

4500

0.72

10.47

1.3

241.27

251.27

u/ml

0.11

421

4081

Raynaud syndrome

319

2174

1.51

10.41

1.3

176.36

194.04

u/ml

0.20

296

2009

Secondary and unspecified malignant neoplasm of lymph nodes

242

1552

1.60

10.38

1.5

1.3

402.91

248.12

u/ml

0.55

206

1433

Synovial cyst of popliteal space [Baker]

204

1255

1.67

10.37

1.2

240.81

210.41

u/ml

0.19

193

1142

Calcific tendinitis of shoulder

191

1159

1.70

10.34

1.3

1.2

132.63

183.42

u/ml

1.30

175

1063

Perioral dermatitis

103

522

2.11

10.33

1.7

1.2

196.01

222.92

u/ml

0.13

482

Infections with a predominantly sexual mode of transmission

1232

10152

1.23

10.31

1.3

280.58

208.79

u/ml

1.15

1127

9431

Alzheimer disease

314

3363

0.68

10.29

1.2

1.3

250.09

244.26

u/ml

0.05

278

3030

Corneal ulcer

608

4615

1.34

10.29

1.4

1.3

497.56

208.78

u/ml

1.00

561

4265

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

600

4408

1.35

10.25

1.3

207.27

258.98

u/ml

1.05

575

4089

Excessive vomiting in pregnancy

358

2506

1.48

10.25

1.4

1.3

101.72

198.93

u/ml

1.69

340

2332

Benign neoplasm: Sigmoid colon

497

3660

1.38

10.24

1.3

306.78

233.85

u/ml

0.33

459

3338

Fall on and from stairs and steps

811

6393

1.29

10.24

1.4

1.3

226.41

232.69

u/ml

0.09

743

5902

Tuberculosis

145

814

1.83

10.22

1.5

1.2

227.27

235.58

u/ml

0.05

132

741

106

544

2.07

10.22

1.3

1.2

206.59

185.39

u/ml

0.15

508

Cerebral palsy and other paralytic syndromes

364

2550

1.46

10.17

1.4

1.3

193.56

224.50

u/ml

0.42

337

2362

Other acute skin changes due to ultraviolet radiation

118

626

1.97

10.17

1.4

1.2

559.02

177.09

u/ml

1.20

109

576

Respiratory conditions due to other external agents

337

2.36

10.13

1.3

1.2

483.53

256.32

u/ml

0.48

298

Abrasion of teeth

1160

9531

1.23

10.11

1.4

1.3

173.05

225.02

u/ml

1.42

1064

8819

Medial epicondylitis

142

801

1.85

10.09

1.4

1.2

137.70

194.07

u/ml

0.75

134

733

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1042

8433

1.25

10.08

1.3

381.58

213.61

u/ml

0.98

956

7838

Sleep disorders, other/unspecified

152

877

1.82

10.08

1.4

1.3

242.80

272.99

u/ml

0.10

145

809

Epilepsy

895

7123

1.27

10.05

1.3

169.69

260.49

u/ml

3.00

801

6569

Oral lichen planus, including avohilmo , including avohilmo

230

1474

1.62

10.05

1.2

1.3

101.47

179.53

u/ml

2.92

217

1362

Radial styloid tenosynovitis [de Quervain]

206

1285

1.66

10.04

1.2

178.96

215.56

u/ml

0.28

193

1181

Viral hepatitis, IBD co-morbidity

160

930

1.76

10.04

1.2

168.56

339.59

u/ml

1.91

146

863

Hyperimmunoglobulin E [IgE] syndrome

37.64

10.04

5.7

1.2

3870.38

70.91

u/ml

—

Dysplasia of cervi uteri

960

5578

1.27

10.03

1.2

1.3

238.16

194.79

u/ml

0.48

884

5181

Anogenital herpesviral [herpes simplex] infection

450

3287

1.41

10.00

1.5

1.3

431.16

199.63

u/ml

0.51

414

3050

Cerebral cysts

212

1334

1.65

10.00

1.4

1.3

329.41

208.08

u/ml

0.42

190

1238

Herpesviral keratitis and keratoconjunctivitis

147

840

1.82

9.97

1.9

1.2

1629.24

177.85

u/ml

1.28

133

772

Other specified/unspecified bacterial intestinal infections

214

1349

1.64

9.97

1.5

1.3

286.04

212.22

u/ml

0.46

199

1241

Monoarthritis, not elsewhere classified

141

795

1.84

9.96

1.3

285.66

228.77

u/ml

0.16

128

733

Dementia, including avohilmo

633

5674

0.76

9.96

1.3

251.14

247.43

u/ml

0.04

562

5156

Other/unspecified soft tissue disorders related to use, overuse and pressure

111

584

1.99

9.86

1.4

1.2

124.02

207.35

u/ml

0.83

103

531

Exclusions for E4_PCOS_CONSORTIUM

2948

16297

1.14

9.86

1.3

184.98

215.33

u/ml

0.87

2724

15084

Other predominantly sexually transmitted diseases, not elsewhere classified

853

6813

1.27

9.80

1.3

296.85

226.78

u/ml

0.74

772

6342

Calculus of kidney and ureter

812

6434

1.28

9.78

1.3

270.34

259.53

u/ml

0.09

760

5956

DVT of lower extremities

507

3773

1.36

9.76

1.4

1.3

217.80

238.59

u/ml

0.22

465

3478

Scleritis and episcleritis

231

1493

1.60

9.76

1.4

1.3

184.93

179.21

u/ml

0.05

217

1376

Persons encountering health services for specific procedures, not carried out

288

1947

1.52

9.74

1.4

1.3

432.75

211.07

u/ml

0.91

257

1800

Temporal arteritis

104

536

2.02

9.72

1.3

1.2

199.39

222.08

u/ml

0.12

484

Superficial injury of abdomen, lower back and pelvis

506

3774

1.37

9.70

1.4

1.3

198.71

229.58

u/ml

0.46

467

3499

Polyp of the female genital tract

1066

4972

1.25

9.64

1.3

121.77

191.84

u/ml

5.20

985

4589

Other infectious diseases

268

1788

1.54

9.63

1.5

1.3

310.84

234.48

u/ml

0.51

253

1652

Substance abuse, excluding more controls

1810

13212

1.18

9.60

1.3

476.95

246.77

u/ml

4.44

1671

12313

Morphin

243

2.54

9.59

1.3

1.2

106.60

186.89

u/ml

1.27

216

Sacrococcygeal disorders, not elsewhere classified

120

654

1.92

9.59

1.4

1.3

243.15

208.58

u/ml

0.15

113

607

Nail disorders

281

1898

1.52

9.58

1.4

1.3

265.28

204.02

u/ml

0.37

259

1756

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

628

4696

1.32

9.58

1.3

207.80

253.87

u/ml

0.94

601

4353

Haemorrhage, not elsewhere classified

103

531

2.01

9.57

1.3

1.2

142.67

265.42

u/ml

1.21

488

Other disorders of nervous system

204

1284

1.64

9.56

1.4

1.3

268.13

202.43

u/ml

0.33

183

1183

Pyothorax

124

681

1.89

9.55

1.4

1.3

165.89

257.52

u/ml

1.11

114

629

Cardiomyopathy

428

3111

1.40

9.55

1.4

1.3

228.58

295.86

u/ml

0.95

407

2866

Tongue abnormality

194

1209

1.66

9.52

1.4

1.3

185.53

200.72

u/ml

0.13

183

1105

Presence of other devices

582

4414

1.33

9.51

1.3

169.85

249.66

u/ml

3.20

539

4064

Other congenital malformations of skin

308

2125

1.49

9.51

1.5

1.3

164.40

200.99

u/ml

0.64

281

1969

Other ulcerative colitis

213

1359

1.62

9.51

1.4

1.3

214.72

207.57

u/ml

0.04

197

1264

Systemic sclerosis (FG)

467

2.10

9.50

1.4

1.2

77.84

213.96

u/ml

1.78

426

Injuries to unspecified part of trunk, limb or body region

322

2235

1.48

9.50

1.4

1.3

165.75

216.43

u/ml

1.03

296

2065

Other/unspecified cytomegaloviral diseases

381

2.24

9.47

1.7

1.3

547.57

260.60

u/ml

0.48

350

Superficial injury of thorax

445

3265

1.39

9.47

1.2

1.3

217.57

232.30

u/ml

0.19

405

3015

Bicipital tendinitis

149

868

1.78

9.42

1.3

1.2

164.00

218.10

u/ml

0.43

139

795

Other disorders of penis

260

1730

1.54

9.42

1.4

1.3

308.19

340.06

u/ml

0.16

244

1598

Congenital malformations of the circulatory system

523

3823

1.36

9.41

1.2

1.3

186.77

256.68

u/ml

1.55

490

3552

Disorders of mineral metabolism

254

1685

1.55

9.40

1.3

267.91

219.84

u/ml

0.17

236

1552

Event of undetermined intent

236

1546

1.58

9.37

1.5

1.3

253.11

224.08

u/ml

0.19

222

1424

Vitamin deficiency, wide

158

938

1.74

9.36

1.4

1.3

229.91

192.83

u/ml

0.30

146

860

Vitamin deficiency

158

938

1.74

9.36

1.4

1.3

229.91

192.83

u/ml

0.30

146

860

Phobic anxiety disorders

530

4001

1.35

9.35

1.3

164.30

237.65

u/ml

2.46

481

3714

Hodgkin lymphoma, hilmo

106

560

1.99

9.34

1.4

1.3

312.64

263.22

u/ml

0.16

517

Other superficial mycoses

379

2721

1.43

9.33

1.3

211.26

220.99

u/ml

0.11

356

2515

Thyrotoxicosis, other and/or unspecified

666

5190

1.30

9.32

1.4

1.3

186.88

208.07

u/ml

0.37

625

4777

Bacterial, viral and other infectious agents

295

2024

1.50

9.31

1.5

1.3

219.45

257.79

u/ml

0.39

284

1880

Benign lipomatous neoplasm

883

7111

1.26

9.31

1.3

176.69

234.85

u/ml

2.04

820

6544

Epiphora

390

2.19

9.26

1.2

228.50

223.33

u/ml

0.02

354

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgE [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS